| Notes forming part of accounts [line items] | | |
| Disclosure of notes and other explanatory information [text block] | | |
| Disclosure of general information about reporting entity [abstract] | | |
| Disclosure of basis of preparation of financial statements [text block] | 2. BASIS OF PREPARATIONa) Statement of complianceThese financial statements of the Company have been prepared in accordance with International Financial Reporting Standards (IFRSs) that are endorsed in the Kingdom of Saudi Arabia and other standards and pronouncements endorsed by the Saudi Organization for Certified Public Accountants (“SOCPA”) and the Regulations for Companies in the Kingdom of Saudi Arabia.b) Basis of presentation and measurementThese financial statements have been prepared under going concern basis and historical cost convention except for the measurement at fair value of investments held as fair value through statement of income (FVSI) and employees’ defined benefit obligations which is recognized at the present value of future obligations using the projected unit credit method. The Company’s statement of financial position is not presented using a current/non-current classification. However, the following balances would generally be classified as current: cash and cash equivalents, short term deposits, premiums and reinsurers’ receivable - net, reinsurers’ share of unearned premiums, deferred policy acquisition costs, deferred excess of loss premiums, prepaid expenses and other assets, policyholders payable, reinsurers balances payable, accrued and other liabilities, unearned premiums, unearned reinsurance commission, outstanding claims, claims incurred but not reported, premium deficiency reserve, other technical reserves and Zakat and income tax payable. All other financial statement line items would generally be classified as non-current unless stated otherwise.The Company presents its statement of financial position in order of liquidity. As required by the Saudi Arabian Insurance Regulations, the Company maintains separate books of accounts for “Insurance Operations” and “Shareholders’ Operations” and presents the financial statements accordingly (note 30). Assets, liabilities, revenues and expenses clearly attributable to either activity are recorded in the respective accounts. The basis of allocation of expenses from joint operations is determined and approved by the management and the Board of Directors.The statement of financial position, statements of income, statement of other comprehensive income and cash flows of the insurance operations and shareholders’ operations which are presented in Note 29 of the financial statements have been provided as supplementary financial information and to comply with the requirements of the guidelines issued by SAMA implementing regulations. SAMA implementing regulations require the clear segregation of the assets, liabilities, income and expenses of the insurance operations and the shareholders’ operations. Accordingly, the statements of financial position, statements of income, statement of other comprehensive income and cash flows prepared for the insurance operations and shareholders operations as referred to above, reflect only the assets, liabilities, income, expenses and comprehensive gains or losses of the respective operations. (Note 29) 2. BASIS OF PREPARATION – (continued)b) Basis of presentation and measurement – (continued)In preparing the Company-level financial statements in compliance with IFRS, the balances and transactions of the insurance operations are amalgamated and combined with those of the shareholders’ operations. The accounting policies adopted for the insurance operations and shareholders’ operations are uniform for like transactions and events in similar circumstances.The inclusion of separate information of the insurance operations with the financial information of the Company in the statement of financial position, the statement of income, statement of comprehensive income, cash flows as well as certain relevant notes to the financial information represents additional supplementary information required as required by the implementing regulations.As per the by-laws of the Company, surplus arising from the Insurance Operations is distributed as follows:Transfer to Shareholders’ operations 90%Transfer to Policyholders’ operations 10% 100%In case of deficit arising from the insurance operations, the entire deficit is allocated and transferred to the shareholders’ operations in full.In accordance with Article 70 of SAMA implementing regulations, the Company proposes to distribute, subject to the approval of SAMA, its annual net policyholders’ surplus directly to policyholders at a time, and according to criteria, as set by its Board of Directors.c) Functional and presentation currencyThese financial statements have been presented in Saudi Arabian Riyals (“SAR”), which is also the functional currency of the Company. All financial information presented in SAR has been rounded to the nearest thousands, except where otherwise indicated.d) Fiscal yearThe Company’s fiscal year is aligned with the calendar year i.e. it begins at 1 January and ends at 31 December.e) Critical accounting judgments, estimates and assumptionsThe preparation of the financial statements requires the use of estimates and judgments that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting year. Although these estimates and judgments are based on management’s best knowledge of current events and actions, actual results ultimately may differ from those estimates.Estimates and judgments are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. In preparing these financial statements, the significant judgments made by management in applying the Company’s accounting policies and the key sources of estimation uncertainty including the risk management policies were the same as those that applied to the annual financial statements as at and for the year ended 31 December 2019. However, the Company has reviewed the key sources of estimation uncertainties disclosed in the last annual financial statements against the backdrop of the COVID-19 pandemic. For further details, please see note 34 to these financial statements. Management will continue to assess the situation and reflect any required changes in future reporting periods.Estimates and judgments are continually evaluated and based on historical experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Following are the accounting judgments and estimates that are critical in preparation of these financial statements: 2. BASIS OF PREPARATION – (continued)e) Critical accounting judgments, estimates and assumptions – (continued)i) The ultimate liability arising from claims made under insurance contractsThe estimation of the ultimate liability arising from claims made under insurance contracts is the Company’s most critical accounting estimate. There are several sources of uncertainty that need to be considered in the estimate of the liability that the Company will ultimately pay for such claims. Estimates are made at the end of the reporting year both for the expected ultimate cost of claim reported and for the expected ultimate costs of claims incurred but not reported (“IBNR”). Liabilities for unpaid reported claims are estimated using the input of assessments for individual cases reported to the Company. At the end of each reporting year, prior year claims estimates are reassessed for adequacy and changes are made to the provision.The provision for claims incurred but not reported (IBNR) is an estimation of claims which are expected to be reported subsequent to the date of statement of financial position, for which the insured event has occurred prior to the date of statement of financial position. The primary technique adopted by management in estimating the cost of notified and IBNR claims is that of using the past claims settlement trends to predict future claims settlement trends. A range of methods such as Chain Ladder Method, Bornhuetter-Ferguson Method and Expected Loss Ratio Method are used by the actuaries to determine these provisions. The actuary had also used a segmentation approach including analyzing cost per member per year for medical line of business. Underlying these methods are a number of explicit or implicit assumptions relating to the expected settlement amount and settlement patterns of claims.ii) Impairment financial assetsThe Company determines that financial assets are impaired when there has been a significant or prolonged decline in the fair value of the financial assets below its cost. The determination of what is significant or prolonged requires judgment. A period of 12 months or longer is considered to be prolonged and a decline of 30% from the original cost is considered significant as per the Company’s policy. In making this judgment, the Company evaluates among other factors, the normal volatility in share price, the financial health of the investee, industry and sector performance, changes in technology, and operational and financing cash flows.iii) Impairment of receivablesA provision for impairment of receivables is established when there is objective evidence that the Company will not be able to collect all amounts due according to the original terms of the receivables. Significant financial difficulties of the debtor, probability that the debtor will enter into bankruptcy or financial reorganization, and default or delinquency in payments are considered indicators that the receivable is impaired. The Company is exposed to disputes with, and the possibility of defaults by, its reinsurers. The Company monitors on a quarterly basis the evolution of disputes with and the strength of its reinsurers.iv) Deferred policy acquisition costsCertain acquisition costs related to the sale of new policies are recorded as deferred acquisition costs (DAC) and are amortized in the statement of insurance operations and accumulated surplus over the related period of policy coverage. If the assumptions relating to future profitability of these policies are not realized, the amortization of these costs could be accelerated and this may also require additional impairment write-offs in the statement of insurance operations and accumulated surplus.v) Premium deficiency reserveEstimation of premium deficiency reserve is highly sensitive to a number of assumptions as to future events and conditions. It is based on an expected loss ratio for the unexpired portion of the risks for written policies. To arrive at the estimate of the expected loss ratio, the Company’s actuarial team and the independent actuary, consider the claims and premiums relationship which is expected to apply on a monthly basis, and ascertain, at the end of the financial year, whether a premium deficiency reserve is required. 2. BASIS OF PREPARATION – (continued)e) Critical accounting judgments, estimates and assumptions – (continued)vi) Fair value of financial instrumentsThe fair value for financial instruments traded in active markets at the reporting date are based on quoted prices for marketable securities or estimated fair values. The fair value of commission-bearing items is estimated based on discounted cash flows using commission for items with similar terms and risk characteristics.The fair value of financial instruments where no active market exists or where quoted prices are not otherwise available are determined by using valuation techniques. In these cases, the fair values are estimated from observable data in respect of similar financial instruments or using models. Where market observable inputs are not available, they are estimated based on appropriate assumptions. Where valuation techniques (for example, models) are used to determine fair values, they are validated and periodically reviewed by qualified personnel independent of those that sourced them. All models are certified before they are used, and models are calibrated to ensure that outputs reflect actual data and comparative market prices. To the extent practical, models use only observable data; however, areas such as credit risk (both own credit risk and counterparty risk), volatilities and correlations require management to make estimates.vii) Useful lives of property and equipment and intangible assetsThe Company's management determines the estimated useful lives of its property and equipment and intangible assets for calculating depreciation / amortization. These estimates are determined after considering the expected usage of the assets or physical wear and tear. Management reviews the residual value and useful lives annually and future depreciation / amortization charge would be adjusted where the management believes the useful lives differ from previous estimates.viii) Going concernThe Company’s management has made an assessment of its ability to continue as a going concern and is satisfied that it has the resources to continue in business for the foreseeable future. Furthermore, management is not aware of any material uncertainties that may cast significant doubt upon the Company’s ability to continue as a going concern. Therefore, the financial statements continue to be prepared on the going concern basisix) Employees’ terminal benefits The employees’ terminal benefits obligation is determined by an independent actuary using the projected unit credit method as recommended in IAS 19 “Employee benefits”. The present value of the defined benefit obligation is determined by discounting the estimated cash outflows using interest rates of sovereign debt instruments that are denominated in Saudi Riyals and have maturity periods approximating that of the gratuity liability.The present value of the defined benefit obligation depends on several factors that are determined by the actuary using assumptions such as discount rate, expected future salary increases, mortality rates and staff turnover etc. These estimates are subject to significant uncertainty due to their long-term nature and are reviewed at each reporting date.f) Seasonality of operationsThere are no seasonal changes that may affect insurance operations of the Company | 2 |
| Disclosure of other general disclosures about reporting entity [text block] | 1. ORGANIZATION AND PRINCIPAL ACTIVTIESAllied Cooperative Insurance Group (“the Company”) is a Saudi Joint Stock Company registered in the Kingdom of Saudi Arabia under Commercial Registration No. 4030171999 dated 9 Shabaan 1428H, corresponding to 22 August 2007. The activities of the Company are to transact cooperative insurance operations and related activities in the Kingdom of Saudi Arabia. On 4 April 2009, the Company received a license from the Saudi Arabian Monetary Authority (“SAMA”) to engage in insurance in Saudi Arabia. The Company commenced its commercial operations on 1 July 2009. The Company was listed on the Saudi Stock Exchange (Tadawul) on 27 August 2007. There are 3 registered branches as set out below:Branch Commercial Registration Number Place of issuance DateBranch of ACIG 2051043671 Al Khobar 12 Ramadan 1439 HBranch of ACIG 5855035150 Khamis Mushayt 12 Ramadan 1439 HBranch of ACIG 4030204059 Jeddah 12 Ramadan 1439 H | 1 |
| Disclosure of summary of significant accounting policies [abstract] | | |
| Disclosure of summary of significant accounting policies, general comment [text block] |
SIGNIFICANT ACCOUNTING POLICIES
The accounting policies adopted by the Company for the preparation of these financial statements are in accordance with IFRS as endorsed in the KSA and are consistent with those used for the preparation of the annual financial statements for the year ended 31 December 2019 and new amended IFRS and IFRS Interpretations Committee Interpretations (IFRIC) as mentioned in note 3(a) which had no significant impact on the financial position or financial performance of the Company.
The accounting policies used in the preparation of the financial statements are consistent with those followed in the preparation of the Company’s annual financial statements for the year ended 31 December 2019, except where otherwise stated.
(A)New IFRS, International Financial Reporting and Interpretations Committee’s interpretations (IFRIC) and amendments thereof, adopted by the Company
The following new standards, amendments and revisions to existing standards, which were issued by the International Accounting Standards Board (“IASB”), as endorsed in the Kingdom of Saudi Arabia have been effective from 1 January 2020 and accordingly adopted by the Company, as applicable:
Standard/ Amendments | Description | Effective for annual years beginning on or after | Summary of the amendment | Amendments to IAS 1 & IAS 8 | Definition of Material | 1 January 2020 | The amendments provided a new definition of material and clarified that materiality will depend on the nature or magnitude of information, either individually or in combination with other information, in the context of the financial statements. | Amendments to IFRS 3 | Definition of a Business | 1 January 2020 | The amendment clarifies that to be considered a business, an integrated set of activities and assets must include, at a minimum, an input and a substantive process that, together, significantly contribute to the ability to create output. Furthermore, it clarifies that a business can exist without including all of the inputs and processes needed to create outputs. | Amendment to IFRS 7, IFRS 9 and IAS 39 | Interest Rate Benchmark Reforms | 1 January 2020 | The revised Conceptual Framework includes some new concepts, updated definitions and recognition criteria for assets and liabilities and clarifies some important concepts. | Revised Conceptual Framework for Financial Reporting | Amendments to references Conceptual Framework in IFRS Standards and updated definitions and recognition criteria for assets and liabilities and clarifies some important concepts. | 1 January 2020 | The revised Conceptual Framework includes some new concepts, updated definitions and recognition criteria for assets and liabilities and clarifies some important concepts. | IFRS 16 | COVID-19-Related Rent Concessions | 1 June 2020 | The amendments provide relief to lessees from applying IFRS 16 guidance on lease modification accounting for rent concessions arising as a direct consequence of the Covid-19 pandemic. The amendment applies to annual reporting periods beginning on or after 1 June 2020 and earlier application is permitted. |
The adoption of the relevant amended standards and interpretations applicable to the Company did not have any significant impact on these financial statements.
SIGNIFICANT ACCOUNTING POLICIES – (continued))
(B)Standards issued but not yet effective
Standards issued but not yet effective up to the date of issuance of the Company’s financial statements are listed below. The listing is of standards and interpretations issued, which the Company reasonably expects to be applicable at a future date. The Company intends to adopt these standards when they are effective.
Standard/ Interpretation |
Description | Effective from periods beginning on or after the following date | Summary of the amendment | IFRS 9, IAS 39, IFRS 7, IFRS 4 and IFRS 16 (see below) | Interest Rate Benchmark Reform – Phase 2 | 1 January 2021 | These amendments modify specific hedge accounting requirements to allow hedge accounting to continue for affected hedges during the period of uncertainty before the hedged items or hedging instruments affected by the current interest rate benchmarks are amended as a result of the on-going interest rate benchmark reforms. The amendments also introduce new disclosure requirements to IFRS 7 for hedging relationships that are subject to the exceptions introduced by the amendments to IFRS 9. | IAS 37 | Onerous Contracts – Cost of Fulfilling a Contract | 1 January 2022 | The amendments specify that the ‘cost of fulfilling’ a contract comprises the ‘costs that relate directly to the contract. These amendments apply to contracts for which the entity has not yet fulfilled all its obligations at the beginning of the annual reporting period in which the entity first applies the amendments. | IFRS 16, IFRS 9, IAS 41 and IFRS 1 | Annual Improvements to IFRS Standards 2018–2020 | 1 January 2022 | IFRS 16: The amendment removes the illustration of the reimbursement of leasehold improvements IFRS 9: The amendment clarifies that in applying the ‘10 per cent’ test to assess whether to derecognize a financial liability, an entity includes only fees paid or received between the entity (the borrower) and the lender. The amendment is to be applied prospectively to modifications and exchanges that occur on or after the date the entity first applies the amendment. IAS 41: The amendment removes the requirement in IAS 41 for entities to exclude cash flows for taxation when measuring fair value. IFRS 1: The amendment provides additional relief to a subsidiary which becomes a first-time adopter later than its parent in respect of accounting for cumulative translation difference. | IFRS 17 | Insurance Contracts (note below) | 1 January 2023 | This is comprehensive new accounting standard for insurance contracts covering recognition and measurement, presentation and disclosure. Once effective, IFRS 17 will replace IFRS 4 Insurance Contracts (IFRS 4) that was issued in 2005. |
IFRS 9 - Financial Instruments
This standard was published on 24 July 2014 and has replaced IAS 39. The new standard addresses the following items related to financial instruments:
SIGNIFICANT ACCOUNTING POLICIES – (continued))
(B)Standards issued but not yet effective – (continued)
IFRS 9 - Financial Instruments – (continued)
Classification and measurement:
IFRS 9 uses a single approach to determine whether a financial asset is measured at amortized cost, fair value through other comprehensive income or fair value through profit or loss. A financial asset is measured at amortized cost if both:
the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows; and
the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding (“SPPI”).
The financial asset is measured at fair value through other comprehensive income and realized gains or losses would be recycled through profit or loss upon sale, if both conditions are met:
the asset is held within a business model whose objective is to hold assets in order to collect contractual cash flows and for sale; and
the contractual terms of cash flows are SPPI.
Debt financial assets not meeting either of these categories are measured at fair value through profit or loss. Additionally, at initial recognition, an entity can use the option to designate a financial asset, both debt and equity instrument at fair value through profit or loss if doing so eliminates or significantly reduces an accounting mismatch.
For equity instruments that are not held for trading, an entity can also make an irrevocable election to present in other comprehensive income subsequent changes in the fair value of the instruments (including realized gains and losses), dividends being recognized in statement of income.
Additionally, for financial liabilities that are designated as at fair value through profit or loss, the amount of change in the fair value of the financial liability that is attributable to changes in the credit risk of that liability is recognized in other comprehensive income, unless the recognition of the effects of changes in the liability’s credit risk in other comprehensive income would create or enlarge an accounting mismatch in statement of income.
Impairment:
The impairment model under IFRS 9 reflects expected credit losses, as opposed to incurred credit losses under IAS 39. Under the IFRS 9 approach, it is no longer necessary for a credit event to have occurred before credit losses are recognized. Instead, an entity always accounts for expected credit losses and changes in those expected credit losses. The amount of expected credit losses is updated at each reporting date to reflect changes in credit risk since initial recognition.
Hedge accounting
IFRS 9 introduces new requirements for hedge accounting that align hedge accounting more closely with Risk Management. The requirements establish a more principles-based approach to the general hedge accounting model. The amendments apply to all hedge accounting with the exception of portfolio fair value hedges of interest rate risk (commonly referred to as “fair value macro hedges”). For these, an entity may continue to apply the hedge accounting requirements currently in IAS 39. This exception was granted largely because the IASB is addressing macro hedge accounting as a separate project.
SIGNIFICANT ACCOUNTING POLICIES – (continued))
(B)Standards issued but not yet effective – (continued)
IFRS 9 - Financial Instruments – (continued)
Effective date
The published effective date of IFRS 9 was 1 January 2018. However, amendments to IFRS 4 – Insurance Contracts: Applying IFRS 9 – Financial Instruments with IFRS 4 – Insurance Contracts, published on 12 September 2016, changes the existing IFRS 4 to allow entities issuing insurance contracts within the scope of IFRS 4 to mitigate certain effects of applying IFRS 9 before the IASB’s new insurance contract standard (IFRS 17 – Insurance Contracts) becomes effective. The amendments introduce two alternative options:
1.Apply a temporary exemption from implementing IFRS 9 until the earlier of
the effective date of a new insurance contract standard; or
annual reporting periods beginning on or after 1 January 2021. On 17 March 2020, the International Accounting Standards Board (“IASB”) decided to extend the effective date of IFRS 17 and the IFRS 9 temporary exemption in IFRS 4 from 1 January 2021 to 1 January 2023. Additional disclosures related to financial assets are required during the deferral period. This option is only available to entities whose activities are predominately connected with insurance and have not applied IFRS 9 previously; or
2.Adopt IFRS 9 but, for designated financial assets, remove from profit or loss the effects of some of the accounting mismatches that may occur before the new insurance contract standard is implemented. During the year, additional disclosures are required.
The Company has performed a detailed assessment beginning 1 January 2017: (1) The carrying amount of the Company’s liabilities arising from contracts within the scope of IFRS 4 (including deposit components or embedded derivatives unbundled from insurance contracts) were compared to the total carrying amount of all its liabilities; and (2) the total carrying amount of the company’s liabilities connected with insurance were compared to the total carrying amount of all its liabilities. Based on these assessments the Company determined that it is eligible for the temporary exemption. Consequently, the Company has decided to defer the implementation of IFRS 9 until the effective date of the new insurance contracts standard. Disclosures related to financial assets required during the deferral period are included in the Company’s annual financial statements for the year ended 31 December 2019.
Impact assessment
Overall, the Company expects some impact of applying the impairment requirements of IFRS 9 on the financial statements of the Company. However, the impact of the same is not expected to be significant. At present it is not possible to provide reasonable estimate of the effects of application of this new standard as the Company is yet to perform a detailed review.
SIGNIFICANT ACCOUNTING POLICIES – (continued))
(B)Standards issued but not yet effective – (continued)
IFRS 17 - “Insurance Contracts”
Overview
This standard has been published on 18 May 2017, it establishes the principles for the recognition, measurement, presentation and disclosure of insurance contracts and supersedes IFRS 4 – Insurance contracts.
The new standard applies to insurance contracts issued, to all reinsurance contracts and to investment contracts with discretionary participating features provided the entity also issues insurance contracts. It requires to separate the following components from insurance contracts:
a.embedded derivatives, if they meet certain specified criteria; b.distinct investment components; and c.any promise to transfer distinct goods or non-insurance services.
These components should be accounted for separately in accordance with the related standards (IFRS 9 and IFRS 15).
Measurement
In contrast to the requirements in IFRS 4, which permitted insurers to continue to use the accounting policies for measurement purposes that existed prior to January 2015, IFRS 17 provides the following different measurement models:
The General model is based on the following “building blocks”:
a.the fulfilment cash flows (FCF), which comprise: probability-weighted estimates of future cash flows; an adjustment to reflect the time value of money (i.e. discounting) and the financial risks associated with those future cash flows; and a risk adjustment for non-financial risk.
b.the Contractual Service Margin (CSM). The CSM represents the unearned profit for a group of insurance contracts and will be recognized as the entity provides services in the future. The CSM cannot be negative at inception; any net negative amount of the fulfilment cash flows at inception will be recorded in profit or loss immediately. At the end of each subsequent reporting period the carrying amount of a group of insurance contracts is remeasured to be the sum of:
the liability for remaining coverage, which comprises the FCF related to future services and the CSM of the group at that date; and the liability for incurred claims, which is measured as the FCF related to past services allocated to the group at that date.
The CSM is adjusted subsequently for changes in cash flows related to future services but the CSM cannot be negative, so changes in future cash flows that are greater than the remaining CSM are recognized in profit or loss. Interest is also accreted on the CSM at rates locked in at initial recognition of a contract (i.e. discount rate used at inception to determine the present value of the estimated cash flows). Moreover, the CSM will be released into profit or loss based on coverage units, reflecting the quantity of the benefits provided and the expected coverage duration of the remaining contracts in the group.
The Variable Fee Approach (VFA) is a mandatory model for measuring contracts with direct participation features (also referred to as ‘direct participating contracts’). This assessment of whether the contract meets these criteria is made at inception of the contract and not reassessed subsequently. For these contracts, the CSM is also adjusted in addition to adjustment under general model;
I.changes in the entity’s share of the fair value of underlying items; and II.changes in the effect of the time value of money and financial risks not relating to the underlying items.
SIGNIFICANT ACCOUNTING POLICIES – (continued))
(B)Standards issued but not yet effective – (continued)
IFRS 17 - “Insurance Contracts” – (continued)
Effective date
The Company intends to apply the Standard on its effective date i.e. 1 January 2023. The IASB issued an Exposure Draft Amendments to IFRS 17 proposing certain amendments to IFRS 17 during June 2019 and received comments from various stakeholders. On 17 March 2020, the IASB completed its discussions on the amendments to IFRS 17 Insurance Contracts that were proposed for public consultation in June 2019. It decided that the effective date of the Standard will be deferred to annual reporting periods beginning on or after 1 January 2023. The IASB expects to issue the amendments to IFRS 17 in the second quarter of 2020. Earlier application is permitted if both IFRS 15 – Revenue from Contracts with Customers and IFRS 9 – Financial Instruments have also been applied.
Transition
Retrospective application is required. However, if full retrospective application for a group of insurance contracts is impracticable, then the entity is required to choose either a modified retrospective approach or a fair value approach.
Presentation and Disclosures
The Company expects that the new standard will result in a change to the accounting policies for insurance contracts together with amendments to presentation and disclosures.
Impact:
The Company is currently assessing the impact of the application and implementation of IFRS 17. As of the date of the publication of these financial statements, the financial impact of adopting the standard has yet to be fully assessed by the Company. The Company expects a material impact on measurement and disclosure of insurance and cession that will affect both the statement of income and the statement of financial position. The Company has decided not to early adopt this new standard.
The Company has started its implementation process and has set up a project team, supervised by an IFRS executive management committee.
Impact area | Summary of impact | Financial impact | As per the analysis on underwriting year 2018, the financial impact was observed to be minor in proportion to the overall equity as the Company's insurance contracts are mostly short-termed and short tailed entitling for premium allocation approach (PAA) which is largely similar to current account practice. | Data impact | IFRS 17 has additional data requirements (e.g. premium due date for initial recognition, premium receipt data for the LFRC, RI contracts held break down into risk attaching or loss incurring for assessing contract boundaries, lower granularity to meet level of aggregation requirements and data for additional disclosures as per IFRS 17). Further extensive exercise is being carried out to ensure the required data is made available. | IT systems impact | The company has identified the need for IFRS-17 accounting engine. A solution vendor is expected to be finalized by Q1 of 2021. | Process impact | The company carried out an operational impact assessment exercise to assess the operational impact of implementing IFRS 17. Since, majority of the company’s contracts would be measured under the premium allocation approach, the process impact is expected to be moderate. | Impact on Reinsurance arrangements | Further assessment is being done to confirm measurement approach for reinsurance arrangements where RI gross premium ceded does not automatically qualify for PAA. | Impact on policies and control frameworks | The Company's policies and procedures needs update to accommodate the changes in the Company's processes and systems related to IFRS 17 implementation. Detailed exercise for the purpose is being carried out as part of Phase III of SAMA implementation guidelines. |
SIGNIFICANT ACCOUNTING POLICIES – (continued))
(B)Standards issued but not yet effective – (continued)
IFRS 17 - “Insurance Contracts” – (continued)
Impact: – (continued)
The Company is currently in design phase of IFRS 17 implementation which requires developing and designing new processes and procedures for the business including any system developments required under IFRS 17 and detailed assessment of business requirements. Following are the main areas under design phase and status of the progress is as follows:
Major areas of design phase | Summary of progress | Governance and control framework | The Company has put in place a comprehensive IFRS 17 governance program which includes establishing oversight steering committee for monitoring the progress of implementation and assigning roles and responsibilities to various stakeholders. | Operational area | The Company is in progress of designing operational aspects of the design phase which includes establishing comprehensive data policy and data dictionary. Also the Company is finalizing architectural designs for various sub-systems. The Company has progressed through assessment of business requirements and currently working on vendor selection while finalizing various process needed for transition and assessment of new resources needed. | Technical and financial area | The Company has completed various policy papers encompassing various technical and financial matters after concluding on policy decisions required under the IFRS 17 standard. The policy decisions are taken after due deliberations among various stakeholders. Currently policy papers are in approval process by the Company's IFRS 17 project steering committee. | Assurance plan | The Company is working along with other stakeholders to finalize the assurance plan for transitional and post-implementation periods. |
SIGNIFICANT ACCOUNTING POLICIES – (continued))
Insurance contracts
Insurance contracts are defined as those containing insurance risk at the inception of the contract or those where at the inception of the contract there is a scenario with commercial substance of existence of insurance risk. This insurance risk is dependent on both the probability of an insured event and the magnitude of its potential effect.
Once a contract has been classified as an insurance contract, it remains an insurance contract for the remainder of its lifetime, even if the insurance risk reduces significantly during this year.
Insurance contracts are principally divided into marine, property, motor, engineering and accident and liability and are principally short term insurance contracts.
Marine insurance is designed to compensate contract holders for damage and liability arising through loss or damage to marine craft and accidents at sea resulting in the total or partial loss of cargoes. For marine insurance, the main risks are loss or damage to marine craft and accidents resulting in the total or partial loss of cargoes.
Property insurance contracts mainly compensate the Company’s customers for damage suffered to their properties or for the value of property lost. Customers who undertake commercial activities on their premises could also receive compensation for the loss of earnings caused by the inability to use the insured properties in their business activities (business interruption cover). For property insurance contracts, the main risks are fire, business interruption and burglary.
Motor insurance is designed to compensate contract holders for damages suffered to their vehicles or liability to third parties arising through accidents. Contract holders could also receive compensation for fire or theft of their vehicles. In Saudi Arabia, it is compulsory for all vehicles to have minimum third party cover. The Company also issues comprehensive motor policies. Such motor policies cover damages to vehicles due to storm, tempest, flood, fire, theft and personal accident.
Accident insurance includes money insurance, fidelity guarantee insurance, business all risk insurance, business travel insurance and exhibition insurance. Liability insurance includes general third-party liability, product liability, workmen’s compensation/employer’s liability and professional indemnity cover protecting the insured’s legal liability arising out of acts of negligence during their business operations.
Engineering insurance covers two principal types (a) “Contractors all risk” insurance offering cover during erection or construction of buildings or civil engineering works such as houses, shops, blocks of flats, factory buildings, roads, buildings, roads, bridges, sewage works and reservoirs. (b) “Erection all risk” insurance offering cover during the erection or installation of plant and machinery such as power stations, oil refineries, chemical works, cement works, metallic structures or any factory with plant and machinery. The Engineering line of business also includes machinery breakdown insurance and electronic equipment insurance.
Medical insurance is designed to compensate holders for expenses incurred in treatment of a disease, illness or injury. Medical insurance is primarily offered to corporate customers with a large population to be covered under the policy.
Claim and loss adjustment expenses are charged to income as incurred based on the estimated liability for compensation owed to contract holders or third parties damaged by the contract holders. They include direct and indirect claims settlement costs and arise from events that have occurred up to the balance sheet date even if they have not yet been reported to the Company. The Company does not discount its liabilities for unpaid claims. Liabilities for unpaid claims are estimated using the input of assessments for individual cases reported to the Company and statistical analyses for the claims incurred but not reported and to estimate the expected ultimate cost of more complex claims that may be affected by external factors such as court decisions.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Reinsurance contracts held
In order to optimise financial exposure from large claims, the Company enters into reinsurance agreements with local and internationally reputable reinsurers. Claims receivable from reinsurers are estimated in a manner consistent with the claim liability and in accordance with the reinsurance contracts. These amounts, if any, are shown as “Reinsurers’ share of outstanding claims” in the statement of financial position until the claim is agreed and paid by the Company. Once the claim is paid, the amount due from the reinsurers in connection with the paid claim is transferred to amounts due from / (to) reinsurers.
At each reporting date, the Company assesses whether there is any indication that a reinsurance asset may be impaired. Where an indicator of impairment exists, the Company makes a formal estimate of recoverable amount. Where the carrying amount of a reinsurance asset exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount
Revenue Recognition
Recognition of premium
Premiums and commission are recorded in the statement of income based on straight line method over the insurance policy coverage period except for long term polices (construction and engineering) and marine cargo. Unearned premiums are calculated on a straight line method over the insurance policy coverage except for:
Last three months premium at a reporting date is considered as unearned in respect of marine cargo;
Pre-defined calculation for Engineering class of business for risks undertaken that extend beyond a single year. In accordance with this calculation, lower premiums are earned in the first year which gradually increases towards the end of the tenure of the policy; and
Unearned premiums represent the portion of premiums written relating to the unexpired period of coverage. The change in the provision for unearned premium is taken to the statement of income in the same order that revenue is recognised over the period of risk.
Investment income
Investment income on debt instruments classified under held to maturity investments and murabaha deposits are accounted for on an effective interest basis.
Dividend income
Dividend income on equity instruments classified under fair value through statement of income (FVSI) investments is recognized when the right to receive payment is established.
Claims
Claims consist of amounts payable to policyholders and third parties and related loss adjustment expenses, net of salvage and other recoveries. Gross outstanding claims comprise the gross estimated cost of claims incurred but not settled at the statement of financial position date together with related claims handling costs, whether reported by the insured or not. Provisions for reported claims not paid as of the statement of financial position date are made on the basis of individual case estimates. In addition, a provision based on management’s judgment and the Company’s prior experience is maintained for the cost of settling claims incurred but not reported including related claims handling costs at the statement of financial position date.
The outstanding claims are shown on a gross basis and the related share of the reinsurers is shown separately. Further, the Company does not discount its liability for unpaid claims as substantially all claims are expected to be paid within one year of the statement of financial position date.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Salvage and subrogation reimbursement
Some insurance contracts permit the Company to sell (usually damaged) assets acquired in settling a claim (for example, salvage). The Company may also have the right to pursue third parties for payment of some or all costs (for example, subrogation). Estimates of salvage recoveries are included as an allowance in the measurement of the outstanding claims liability. The allowance is the amount that can reasonably be recovered from the disposal of the asset. Subrogation reimbursements are also considered as an allowance in the measurement of the outstanding claims liability. The allowance is the assessment of the amount that can be recovered from the third party.
Deferred policy acquisition costs
Commissions and other costs directly related to the acquisition and renewal of insurance contracts are deferred and amortized over the terms of the insurance contracts to which they relate, similar to premiums earned. All other acquisition costs are recognized as an expense when incurred. Amortization is recorded in the “Policy acquisition costs” in the statement of income. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset are accounted for by changing the amortization period and are treated as a change in accounting estimate. An impairment review is performed at each reporting date or more frequently when an indication of impairment arises. If the assumptions relating to future profitability of these policies are not realized, the amortization of these costs could be accelerated and this may also require additional impairment write-offs in the statement of income. Deferred policy acquisition costs are also considered in the liability adequacy test at each reporting date.
Liability adequacy test
At each statement of financial position date, liability adequacy tests are performed to ensure the adequacy of the insurance contracts liabilities net of related deferred policy acquisition costs. In performing these tests management uses current best estimates of future contractual cash flows and claims handling and administration expenses. Any deficiency in the carrying amounts is immediately charged to the statement of income by establishing a provision for losses arising from liability adequacy tests accordingly.
Receivables
Premiums receivable are stated at gross written premiums receivable from insurance contracts, less an allowance for any uncollectible amounts. Premiums and reinsurance balances receivable are recognised when due and measured on initial recognition at the fair value of the consideration received or receivable. The carrying value of receivable is reviewed for impairment and whenever events or circumstances indicate that the carrying amount may not be recoverable, the impairment loss is recorded in “Other general and administrative expenses” in the statement of income. Receivable balances are derecognised when the Company no longer controls the contractual rights that comprise the receivable balance, which is normally the case when the receivable balance is sold, or all the cash flows attributable to the balance are passed through to an independent third party. Receivables disclosed in note 5 fall under the scope of IFRS 4 “Insurance contracts”.
Investments
Available-for-sale investments
Available-for-sale financial assets are those non-derivative financial assets that are neither classified as held for trading or held to maturity or loans and receivables, nor are designated at fair value through profit or loss. Such investments are initially recorded at cost, being the fair value of the consideration given including transaction costs directly attributable to the acquisition of the investment and subsequently measured at fair value. Cumulative changes in fair value of such investments are recognized in other comprehensive income in the statement of comprehensive income under “Net change in fair value – Available for sale investments”. Realized gains or losses on sale of these investments are reported in the related statements of income under “Realized gain / (loss) on investments available for sale investments.” Dividend, commission income and foreign currency gain/loss on available-for-sale investments are recognized in the related statements of income or statement of comprehensive income - shareholder’s operations, as part of the net investment income / loss. Any significant or prolonged decline in fair value of available-for-sale investments is adjusted for and reported in the related statement of comprehensive income, as impairment charges. Fair values of available-for-sale investments are based on quoted prices for marketable securities or estimated fair values.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Investments – (continued)
Available-for-sale investments – (continued)
The fair value of commission-bearing items is estimated based on discounted cash flows using commission for items with similar terms and risk characteristics. For unquoted investments, fair value is determined by reference to the market value of a similar investment or where the fair values cannot be derived from active markets, they are determined using a variety of valuation techniques. The input to these models is taken from observable markets where possible, but where this is not feasible, a degree of judgment is required in establishing fair values.
Reclassification:
The Company evaluates whether the ability and intention to sell its AFS financial assets in the near term is still appropriate. When, in rare circumstances, the Company is unable to trade these financial assets due to inactive markets, the Company may elect to reclassify these financial assets if management has the ability and intention to hold the assets for the foreseeable future or until maturity. Reclassification to loans and receivables is permitted when the financial asset meets the definition of loans and receivables and management has the intention and ability to hold these assets for the foreseeable future or until maturity. The reclassification to HTM is permitted only when the entity has the ability and intention to hold the financial asset until maturity. For a financial asset reclassified out of the available-for-sale category, the fair value at the date of reclassification becomes its new amortized cost and any previous gain or loss on that asset that has been recognised in equity is amortized to profit or loss over the remaining life of the investment using the EIR. Any difference between the new amortized cost and the maturity amount is also amortized over the remaining life of the asset using the Effective Interest Rate “EIR”. If the asset is subsequently determined to be impaired, then the amount recorded in equity is reclassified to the statement of income.
Held for sale
Investments in this category are classified if they are held for trading or designated by management as FVSI on initial recognition. Investments classified as trading are acquired principally for the purpose of selling or repurchasing in short term and are recorded in the statement of financial position at fair value. Changes in fair value are recognized in net trading income/loss.
An investment may be designated at FVSI by the management, at initial recognition, if it satisfies the criteria laid down by IAS 39 except for the equity instruments that do not have a quoted price in an active market and whose fair values cannot be reliably measured.
Investments at FVSI are recorded in the statement of financial position at fair value. Changes in the fair value are recognised in the statement of income for the year in which it arises. Transaction costs, if any, are not added to the fair value measurement at initial recognition of FVSI investments. Special commission income and dividend income on financial assets held as FVSI are reflected as either trading income or income from FVSI financial instruments in the statement of income
Reclassification:
Investments at FVSI are not reclassified subsequent to their initial recognition, except that non-derivative FVSI instrument, other than those designated as FVSI upon initial recognition, may be reclassified out of the FVSI fair value through the statement of income (i.e., trading) category if they are no longer held for the purpose of being sold or repurchased in the near term, and the following conditions are met:
If the financial asset would have met the definition of loans and receivables, if the financial asset had not been required to be classified as held for trading at initial recognition, then it may be reclassified if the entity has the intention and ability to hold the financial asset for the foreseeable future or until maturity.
If the financial asset would not have met the definition of loans and receivables, and then it may be reclassified out of the trading category only in ‘rare circumstances’.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Investments – (continued)
Held to maturity
Investments having fixed or determinable payments and fixed maturity that the Company has the positive intention and ability to hold to maturity are classified as held to maturity. Held to maturity investments are initially recognised at fair value including direct and incremental transaction costs and subsequently measured at amortised cost, less provision for impairment in value. Amortised cost is calculated by taking into account any discount or premium on acquisition using an effective yield basis. Any gain or loss on such investments is recognised in the statement of income when the investment is derecognised or impaired.
Reclassification:
Investments classified as held to maturity cannot ordinarily be sold or reclassified without impacting the Comapny’s ability to use this classification and cannot be designated as a hedged item with respect to commission rate or prepayment risk, reflecting the longer-term nature of these investments.
However, sales and reclassifications in any of the following circumstances would not impact the Comapny’s ability to use this classification
Sales or reclassifications that are so close to maturity that the changes in market rate of commission would not have a significant effect on the fair value Sales or reclassifications after the Company has collected substantially all the assets’ original principal Sales or reclassifications attributable to non-recurring isolated events beyond the Comapny’s control that could not have been reasonably anticipated.
De-recognition of financial instruments
The derecognition of a financial instrument takes place when the Company no longer controls the contractual rights that comprise the financial instrument, which is normally the case when the instrument is sold, or all the cash flows attributable to the instrument are passed through to an independent third party and the Company has also transferred substantially all risks and rewards of ownership.
Offsetting
Financial assets and financial liabilities are offset and the net amount reported in the statement of financial position only when there is a currently enforceable legal right to offset the recognised amounts and there is an intention to settle on a net basis, or to realize the assets and settle the liability simultaneously. Income and expense is not offset in the statement of other comprehensive income unless required or permitted by any accounting standard or interpretation.
Trade date accounting
All regular way purchases and sales of financial assets are recognized / derecognized on the trade date (i.e. the date that the Company commits to purchase or sell the assets). Regular way purchases or sales are purchases or sales of financial assets that require settlement of assets within the time frame generally established by regulation or convention in the market place.
Impairment of financial assets
The Company assesses, at each reporting date, whether there is objective evidence that a financial asset or a group of financial assets is impaired. An impairment exists if one or more events that has occurred since the initial recognition of the asset (an incurred ‘loss event’), has an impact on the estimated future cash flows of the financial asset or the group of financial assets that can be reliably estimated.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Impairment of financial assets – (continued)
Evidence of impairment may include:
Significant financial difficulty of the issuer or debtor; A breach of contract, such as a default or delinquency in payments; It becoming probable that the issuer or debtor will enter bankruptcy or other financial reorganization; The disappearance of an active market for that financial asset because of financial difficulties; or Observable data indicating that there is a measurable decrease in the estimated future cash flow from a group of financial assets since the initial recognition of those assets, although the decrease cannot yet be identified with the individual financial assets in the Company, including: Adverse changes in the payment status of issuers or debtors in the Company; or National or local economic conditions at the country of the issuers that correlate with defaults on the assets.
If there is objective evidence that an impairment loss on a financial asset exists, the impairment is determined as follows:
For assets carried at fair value, impairment is the significant or prolong decline in the fair value of the financial asset. For assets carried at amortized cost, impairment is based on estimated future cash flows that are discounted at the original effective commission rate.
For available-for-sale financial assets, the Company assesses at each reporting date whether there is objective evidence that an investment or a group of investments is impaired.
In the case of debt instruments classified as available for sale, the Company assesses individually whether there is an objective evidence of impairment. Objective evidence may include indications that the borrower is experiencing significant financial difficulty, default or delinquency in special commission income or principal payments, the probability that it will enter bankruptcy or other financial reorganization and where observable data indicates that there is a measurable decrease in the estimated future cash flows, such as changes in economic conditions that correlate with defaults. However, the amount recorded for impairment is the cumulative loss measured as the difference between the amortized cost and the current fair value, less any impairment loss on that investment previously recognized in the statement of income and statement of other comprehensive income. If, in a subsequent period, the fair value of a debt instrument increases and the increase can be objectively related to credit event occurring after the impairment loss was recognized in the statement of income and statement of other comprehensive income, the impairment loss is reversed through the statement of income and statement other of comprehensive income.
Impairment of financial assets – (continued)
In the case of debt instruments classified as available for sale, the Company assesses individually whether there is an objective evidence of impairment. Objective evidence may include indications that the borrower is experiencing significant financial difficulty, default or delinquency in special commission income or principal payments, the probability that it will enter bankruptcy or other financial reorganization and where observable data indicates that there is a measurable decrease in the estimated future cash flows, such as changes in economic conditions that correlate with defaults. However, the amount recorded for impairment is the cumulative loss measured as the difference between the amortized cost and the current fair value, less any impairment loss on that investment previously recognized in the statement of income and statement of other comprehensive income. If, in a subsequent period, the fair value of a debt instrument increases and the increase can be objectively related to credit event occurring after the impairment loss was recognized in the statement of income and statement of other comprehensive income, the impairment loss is reversed through the statement of income and statement of other comprehensive income.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Impairment of financial assets – (continued)
For equity investments held as available-for-sale, a significant or prolonged decline in fair value below its cost represents objective evidence of impairment. The impairment loss cannot be reversed through statement of income as long as the asset continues to be recognised i.e. any increase in fair value after impairment has been recorded can only be recognised in other comprehensive income. On derecognition, any cumulative gain or loss previously recognised in other comprehensive income is included in the statement of income under “Realized gain / (loss) on investments available for sale investments”.
The determination of what is ‘significant’ or ‘prolonged’ requires judgement. A period of 12 months or longer is considered to be prolonged and a decline of 30% from original cost is considered significant as per Company policy. In making this judgement, the Company evaluates, among other factors, the duration or extent to which the fair value of an investment is less than its cost.
In making an assessment of whether an investment in debt instrument is impaired, the Company considers the factors such as market’s assessment of creditworthiness as reflected in the bond yields, rating agencies’ assessment of creditworthiness, country’s ability to access the capital markets for new debt issuance and probability of debt being restructured, resulting in holders suffering losses through voluntary or mandatory debt forgiveness. The amount recorded for impairment is the cumulative loss measured as the difference between the amortised cost and the current fair value, less any impairment loss on that investment previously recognised in the statement of income and statement of other comprehensive income.
Intangible assets
Computer software are shown at historical cost. They have a finite useful life and are subsequent carried at cost less accumulated amortization and impairment losses. The Company amortizes computer software with a limited useful life using straight-line method over the following periods:
| Years | IT development and software | 4 |
Property and equipment
Property and equipment are stated at cost less accumulated depreciation and any impairment losses. Subsequent costs are included in the asset’s carrying amount or recognised as a separate asset, as appropriate, only when it is probable that future economic benefits associated with the item will flow to the Company and the cost of the item can be measured reliably. All other repairs and maintenance are charged to the statement of income during the financial period in which they are incurred. Land is not depreciated. The cost of other items of property and equipment is depreciated on the straight line method to allocate the cost over estimated useful lives, as follows:
| Years | Motor Vehicles | 4 | Furniture, fittings and office equipment | 7 | Computers | 4 | Leasehold improvements | 7 |
Gains and losses on disposals are determined by comparing proceeds with carrying amount and are included in the statement of insurance operations and accumulated surplus.
Maintenance and normal repairs which do not materially extend the estimated useful life of an asset are charged to the statement of shareholders’ operations as and when incurred. Major renewals and improvements, if any, are capitalized and the assets so replaced are retired.
The assets’ residual values and useful lives are reviewed at each reporting date and adjusted if appropriate. The carrying values of these assets are reviewed for impairment when event or changes in circumstances indicate that the carrying value may not be recoverable. If any such indication exists and where the carrying values exceed the estimated recoverable amount, the assets are written down to their recoverable amount.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Leases
Definition of lease
Under IFRS 16, a contract is, or contains, a lease if the contract conveys a right to control the use of an identified asset for a period of time in exchange of consideration. The Company assess whether a contract is or contains a lease based on the new definition of a lease. On transition to IFRS 16, the Company elected to apply the practical expedients to grandfather the assessment of which transactions are leases.
As a lessee
The Company leases its offices, and as a lessee, the Company previously classified leases as operating leases based on its assessment of whether the lease transferred substantially all the risks and rewards of ownership. Under IFRS 16, the Company recognizes right-of-use assets and lease liabilities for most leases - i.e. these leases are on balance sheet.
The Company recognizes a right-of-use asset and a lease liability at the lease commencement date. The right-of-use is initially measured at cost, and subsequently at cost less any accumulated depreciation and impairment losses and adjusted with certain remeasurements of lease liability. The cost of right-of-use assets includes the initial measurement of the lease liability adjusted for any lease payments made at or before the commencement date, any initial direct costs incurred and an estimate of costs to dismantle, less any lease incentive received. The estimated useful life of right-of-use assets are determined considering the term of the lease.
The lease liability is initially measured at present value of the lease payments that are not paid at the commencement date, discounted using the Company’s incremental borrowing rate (if the interest rate implicit in the lease is not available).The lease liability is subsequently increased by the interest cost on the lease liability and decreased by the lease payment made. It is remeasured when there is a change in the future lease payments arising from the change in an index or rate, a change in the estimate of the amount expected to be payable under residual value guarantee, or as appropriate, changes in the assessment of whether a purchase or extension option is reasonably certain to be exercised or termination option is reasonably certain not to be exercised. The lessee will generally recognize the amount of the re-measurement of the lease liability as an adjustment to the right-of-use asset.
Lessor accounting under IFRS 16 is substantially unchanged from today’s accounting under IAS 17. Lessors will continue to classify all leases using the same classification principle as in IAS 17 and distinguish between two types of leases: operating and finance leases.
Impairment of non-financial assets
Assets that have an indefinite useful life – for example, land – are not subject to depreciation and are tested annually for impairment. Assets that are subject to depreciation are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount may not be recoverable.
An impairment loss is recognized for the amount by which the asset’s carrying amount exceeds its recoverable amount. The recoverable amount is the higher of an asset’s fair value less costs to sell and value in use. For the purpose of assessing impairment, assets are grouped at the lowest level for which there are separately identifiable cash flows (cash-generating units).
Employees’ terminal benefits
The Company operates an end of service benefit plan for its employees based on the prevailing Saudi Labor Laws. Accruals are made at the present value of expected future payments in respect of services provided by the employees up to the end of the reporting period using the projected unit credit method. Consideration is given to expected future wage and salary levels, experience of employee departures and periods of service. Expected future payments are discounted using market yields at the end of the reporting period of high-quality corporate bonds with terms and currencies that match, as closely as possible, the estimated future cash outflows. The benefit payments obligation is discharged as and when it falls due. Re-measurements (actuarial gains/ losses) as a result of experience adjustments and changes in actuarial assumptions are recognised in statement of other comprehensive income.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Zakat and income tax
The Company is subject to zakat in accordance with the regulations of the General Authority of Zakat and Tax (“GAZT”). Zakat is computed on the Saudi shareholders’ share of equity or net income using the basis defined under the Zakat regulations. Income taxes are computed on the foreign shareholders' share of net adjusted income for the year. Zakat and income tax is accrued on a quarterly basis. Additional amounts payable, if any, at the finalization of final assessments are accounted for when such amounts are determined.
Zakat expense is charged to the profit or loss. Zakat is not accounted for as income tax and as such no deferred tax is calculated relating to zakat.
The Company withholds taxes on certain transactions with non-resident parties in the Kingdom of Saudi Arabia as required under Saudi Arabian Income Tax Law.
Dividend distribution
Dividend distribution to the Company’s shareholders is recognised as a liability in the Company’s financial statements in the period in which the dividends are approved by the Company’s shareholders.
Cash and cash equivalents
Cash and cash equivalents comprise cash in hand and balances with banks including murabaha deposits with less than three months’ maturity from the date of acquisition.
Cash flow statement
The Company’s main cash flows are from insurance operations which are classified as cash flow from operating activities. Cash flows generated from investing and financing activities are classified accordingly.
Provision
Provisions are recognised when the Company has an obligation (legal or constructive) as a result of a past event, and it is probable that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation.
Foreign currencies
Transactions in foreign currencies are recorded in Saudi Arabian Riyals at the exchange rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated to Saudi Riyals at the rate of exchange prevailing at the statement of financial position date. All differences are taken to the statements of income and other comprehensive income. Non-monetary items that are measured in terms of historical cost in a foreign currency are translated using the exchange rate as at the date of the initial transaction and are not subsequently restated. Foreign exchange gains or losses on available-for-sale investments are recognized in “Other income, net” in the statement of income and statement of other comprehensive income. As the Company’s foreign currency transactions are primarily in US dollars, foreign exchange gains and losses are not significant.
Fair values
The fair value of financial assets are based on quoted prices for marketable securities or estimated fair values. The fair value of commission-bearing items is estimated based on discounted cash flow using commission for items with similar terms and risk characteristics.
For financial assets where there is no active market, fair value is determined by reference to the market value of a similar financial assets or where the fair values cannot be derived from active market, they are determined using a variety of valuation techniques. The inputs of this models is taken from observable market where possible, but where this is not feasible, a degree of judgment is required in establishing fair values.
SIGNIFICANT ACCOUNTING POLICIES – (continued)
Operating segments
A segment is a distinguishable component of the Company that is engaged in providing products or services (a business segment), which is subject to risk and rewards that are different from those of other segments. For management purposes, the Company is organized into business units based on their products and services and has the following reportable segments:
Medical provides compensation to policy holders for expenses incurred in treatment of a disease, illness or injury. Motor provides coverage against losses and liability related to motor vehicles. Energy and engineering insurance Other includes property, marine, aviation, accident and liability categories.
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision-maker. The chief operating decision-maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the chief executive officer that makes strategic decisions. No inter-segment transactions occurred during the year.
Statutory reserves
In accordance with the Company’s by-laws, the Company shall allocate 20% of its net income from shareholders operations each year to the statutory reserve until it has built up a reserve equal to the share capital. The reserve is not available for distribution.
Accounts and other payables
Liabilities are recognised for amounts to be paid in the future for goods or services received, whether billed by the Supplier or not.
Provision for outstanding claims
Judgement by management is required in the estimation of amounts due to policyholders and third parties arising from claims made under insurance contracts. Such estimates are necessarily based on assumptions about several factors involving varying degrees of judgement and uncertainty and actual results may differ from management’s estimates resulting in future changes in estimated liabilities. The Company estimates its claims based on its experience of its insurance portfolio. Claims requiring court or arbitration decisions, if any, are estimated individually.
Management reviews its provisions for claims incurred, and claims incurred but not reported, on a monthly basis. Any difference between the provisions at the statement of financial position date and settlements and provisions in the following year is included in the statement of insurance operations and accumulated surplus for that year. The provision for outstanding claims, as at 31 December, is also verified and certified by an independent actuary.
Surplus from insurance operations
Ten-percent (10%) of the net surplus from insurance operations shall be distributed to the policyholders directly, or in the form of reduction in premiums for the next year. The remaining ninety-percent (90%) of the net surplus shall be transferred to the shareholders | 1 |
| Disclosure of notes forming part of accounts [abstract] | | |
| Disclosure of property and equipment [text block] | 1. PROPERTY AND EQUIPMENT, NET Motor Vehicles Furniture, fittings and office equipment ComputerEquipment Leasehold improvements Total2020 Total2019 SR’000 SR’000 SR’000 SR’000 SR’000 SR’000Cost: 1 January 116 7,281 6,493 5,491 19,381 19,002Additions - 135 572 2,735 3,442 37931 December 116 7,416 7,065 8,226 22,823 19,381Accumulated depreciation: 1 January 114 6,502 4,453 4,714 15,783 13,557Charge for the year 1 180 326 1,219 1,726 2,22631 December 115 6,682 4,779 5,933 17,509 15,783Net book value 31 December 2020 1 734 2,286 2,293 5,314 -31 December 2019 2 779 2,040 777 - 3,598 2. INTANGIBLE ASSETS 31 December 2020 31 December 2019 SR’000 SR’000Cost: 1 January 9,449 8,091Additions 732 1,358Disposals - -31 December 10,181 9,449 Accumulated amortization 1 January 4,441 3,527Amortization charge 989 914Disposals - - 31 December 5,430 4,441 Net book value 4,751 5,0083. RIGHT OF USE ASSETS, NET 31 December 2020 31 December 2019 SR’000 SR’000Cost: At beginning of the year 9,985 -Adoption of IFRS 16 - 9,985Additions 88 -As at end of year 10,073 9,985 Accumulated amortization At beginning of the year (2,758) -Charge for the year (2,093) (2,758)As at end of year (4,851) (2,758) Net book value 5,222 7,227 4. LEASE LIABILITIES 31 December 2020 31 December 2019 SR’000 SR’000Liability At beginning of the year 10,306 -Impact of adoption of IFRS 16 - 9,985Finance cost 287 321At end of the year 10,593 10,306 Payments At beginning of the year (3,184) -Paid during year (2,435) (3,184)At end of the year 4,974 7,122 5. COMMITMENTS AND CONTINGENCIESThe Company’s commitments and contingencies are as follows: 31 December 2020 31 December 2019 SR’000 SR’000 Letters of guarantee 2,998 2,998 | 9 |
| Disclosure of investments in available-for-sale investments [text block] | 7. AVAILABLE-FOR-SALE INVESTMENTAll available-for-sale investments are in shareholders’ operationsInvestments of the shareholders’ operations comprise the following: 31 December 2020 31 December 2019 SR’000 SR’000 Available-for-sale investments 49,259 51,106a) Investment securities are classified as follows: Domestic Total 2020 2019 2020 2019 SR’000 SR’000 SR’000 SR’000 Investment in sukuk 20,000 25,000 20,000 25,000Quoted securities 11,177 11,256 11,177 11,256Unquoted securities 1,923 1,923 1,923 1,923 Units in quoted local real estate fund 16,159 12,927 16,159 12,927Total 49,259 51,106 49,259 51,106Movements in available-for-sale investments are as follows: Investment in sukuk Quoted securities Unquoted Securities Units in quoted local real estate fund Total SR’000 SR’000 SR’000 SR’000 SR’000 As at 1 January 2020 25,000 11,256 1,923 12,927 51,106Disposals (5,000) - - - (5,000)Changes in fair value of investments - (79) - 3,232 3,153As at 31 December 2020 20,000 11,177 1,923 16,159 49,259 Investment in sukuks Quoted securities Unquoted Securities Units in quoted local real estate fund Total SR’000 SR’000 SR’000 SR’000 SR’000 As at 1 January 2019 25,000 20,712 1,923 10,099 57,734 Purchases - 10,218 - - 10,218Disposals - (21,578) - - (21,578)Changes in fair value of investments - 1,904 - 2,828 4,732As at 31 December 2019 25,000 11,256 1,923 12,927 51,106 | 7 |
| Disclosure of premiums/ contributions and insurance/ reinsurance or takaful/ retakaful balance receivables [text block] | 1. PREMIUMS AND REINSURERS’ RECEIVABLE, NET Receivables comprise amounts due from the following: 31 December 2020 31 December 2019 SR’000 SR’000 Due from policyholders 78,842 74,438Due from policyholders – related parties 1,881 2,248Due from brokers and agents 21,309 19,547Receivables from reinsurers 5,329 4,984 107,361 101,217Provision for doubtful debts (8,723) (13,077)Premiums and reinsurers’ receivable – net 98,638 88,140 6. PREMIUMS AND REINSURERS’ RECEIVABLE, NET – (continued)Movement in provision for doubtful debts during the year was as follows: 31 December 2020 31 December 2019 SR’000 SR’000 Balance at the beginning of the year 13,077 13,304Release for the year (4,354) (227)Balance at the end of the year 8,723 13,077As at 31 December, the ageing of receivables is as follows: Past due but not impaired Past due and impaired Total Neither past due nor impaired Less than 30 days 31 - 90 days 91 - 180 days 181 - 360 days More than 360 days SR’000 SR’000 SR’000 SR’000 SR’000 SR’000 SR’000 Premium and reinsurance receivables, net - Due from policyholders 78,842 - 11,533 52,910 4,552 4,660 5,187- Due from policyholders – related parties 1,881 - (1) (1) 6 6 1,871- Due from Brokers and agents 21,309 - 1,804 15,412 1,173 1,572 1,348- Receivables from reinsurers 5,329 - 1,805 (100) (149) 1,403 2,370- Provision for doubtful debts (8,723) - - - (858) (1,560) (6,305)2020 98,638 - 15,141 68,221 4,724 6,081 4,471 Past due but not impaired Past due and impaired Total Neither past due nor impaired Less than 30 days 31 - 90 days 91 - 180 days 181 - 360 days More than 360 days SR’000 SR’000 SR’000 SR’000 SR’000 SR’000 SR’000 Premium and reinsurance receivables, net - Due from policyholders 74,438 - 41,540 3,043 20,863 6,206 2,786- Due from policyholders – related parties 2,248 - 10 3 5 142 2,088- Due from Brokers and agents 19,548 - 10,380 2,642 1,272 3,786 1,468- Receivables from reinsurers 4,984 - - 4,984 - - -- Provision for doubtful debts (13,078) - - - (5,789) (2,533) (4,756)2019 88,140 - 51,930 10,672 16,351 7,601 1,586The Company only enters into insurance and reinsurance contracts with recognized, creditworthy third parties. It is the Company’s policy that all customers who wish to trade on credit terms are subject to credit verification procedures. In addition, receivables are monitored on an ongoing basis in order to reduce the Company’s exposure to bad debts.The five largest customers accounts for 7% (31 December 2019: 15%) of the premiums receivable as at 31 December 2020. | 6 |
| Disclosure of cash and cash equivalents [text block] | 4. CASH AND CASH EQUIVALENTS Cash and cash equivalents included in the statement of cash flows comprise the following: 31 December 2020 31 December 2019 SR’000 SR’000Insurance operations Bank balances and cash 53,559 65,320Deposits maturing within 3 months from the acquisition date 19,166 - 72,725 65,320Shareholders’ operations Bank balances and cash 14,201 12,159Deposits maturing within 3 months from the acquisition date * 61,050 - 75,251 12,159 147,976 77,479These deposits earn commission at an average rate of (1.08%) per annum as at 31 December 2020 (31 December 2019: nil).5. TERM DEPOSITS 31 December 2020 31 December 2019 SR’000 SR’000Insurance Operations Term deposits 119,331 138,920Shareholders’ Operations Term deposits - 55,663 - 194,583The term deposits are held with the commercial banks. These term deposits are denominated in Saudi Arabian Riyals and have been an original maturity of more than three months and less than twelve months. The carrying amounts of these term deposits reasonably approximate their fair values at the reporting date. These deposit earn commission at an average of 2.67% per annum as at 31 December 2020 (31 December 2019: 3.11%) | 4 |
| Disclosure of statutory deposit [text block] | 16. STATUTORY DEPOSIT 31 December 2020 31 December 2019 SR’000 SR’000Shareholders’ operations Statutory deposit 30,000 30,000As required by Saudi Arabian Insurance Regulations, the Company deposited 15% (31 December 2019: 15%) of its paid up capital, amounting to SR 30 million in a bank designated by the Saudi Central Bank (SAMA). The Company cannot withdraw this deposit without SAMA’s approval and commission accruing on this deposit is payable to SAMA. | |
| Disclosure of employees' end of service benefits [text block] | 1. EMPLOYEES’ TERMINAL BENEFITSThe Company operates an end of service benefit plan for its employees based on the prevailing Saudi Labor Laws. Accruals are made in accordance with the actuarial valuation under projected unit credit method while the benefit payments obligation is discharged as and when it falls due. The amounts recognized in the statement of financial position and movement in the obligation during the year based on its present value are as follows:17.1 The amounts recognized in the statement of financial position and movement in the obligation during the year based on its present value are as follows: 31 December 2020 31 December 2019 SR’000 SR’000 Present value of defined benefit obligation 14,006 12,01117.2 Movement of defined benefit obligation 31 December 2020 31 December 2019 SR’000 SR’000 Opening balance 12,011 9,789Charge to statement of income 2,243 2,268Charge to statement of other comprehensive income 233 471Payment of benefits during the year (481) (517)Closing balance 14,006 12,01117.3 Reconciliation of present value of defined benefit obligation 31 December 2020 31 December 2019 SR’000 SR’000 Present value of defined benefit obligation as at 1 January 12,011 9,789Current service costs 1,869 1,840Financial costs 374 428Actuarial (loss)/ gain from experience adjustments 233 471Benefits paid during the year (481) (517)Present value of defined benefit obligation as at 31 December 14,006 12,011 17. EMPLOYEES’ TERMINAL BENEFITS – (continued)17.4 Principal actuarial assumptions 31 December 2020 31 December 2019 SR’000 SR’000 Valuation discount rate 2.40% 3.2%Expected rate of increase in salary level across different age bands 1.00% 1.40%The impact of changes in sensitivities on present value of defined benefit obligation is as follows: 2020 2019 SR’000 SR’000Valuation discount rate - Increase by 1% 12,545 10,696- Decrease by 1% 15,744 13,442Expected rate of increase in salary level across different age bands - Increase by 1% 15,890 13,521- Decrease by 1% 12,451 10,611Mortality rate - 1 year Mortality age set back 14,013 11,963- 1 year Mortality age set forward 14,000 11,913Withdrawal turnover - Increase by 10% 14,018 11,948- Decrease by 10% 13,992 11,932 | |
| Disclosure of gross unearned premiums/ contributions [text block] | 8. TECHNICAL RESERVES (INSURANCE OPERATIONS)8.1 Net outstanding claims and reservesNet outstanding claims and reserves comprise of the following: 31 December 2020 31 December 2019 SR’000 SR’000 Gross outstanding claims 26,094 34,024 26,094 34,024 Claims incurred but not reported 68,643 61,887Premium deficiency reserves 9,516 2,308Other technical reserves 2,482 1,716 106,735 99,935Less: - Reinsurers’ share of outstanding claims (11,908) (9,718)- Reinsurers’ share of claims incurred but not reported (8,020) (6,597) (19,928) (16,315)Net outstanding claims and reserves 86,807 83,6208.2 Movement in unearned premiumsMovement in unearned premiums comprise of the following: For the year ended 31 December 2020 Gross Reinsurance Net SR’000 SR’000 SR’000Balance as at the beginning of the year 254,360 (21,323) 233,037Premium written during the year 515,117 (65,657) 449,460Premium earned during the year (505,008) 59,587 (445,421)Balance as at the end of the year 264,469 (27,393) 237,076 For the year ended 31 December 2019 Gross Reinsurance Net SR’000 SR’000 SR’000Balance as at the beginning of the year 252,007 (22,738) 229,269Premium written during the year 529,352 (58,485) 470,867Premium earned during the year (526,999) 59,900 (467,099)Balance as at the end of the year 254,360 (21,323) 233,037 8. TECHNICAL RESERVES (INSURANCE OPERATIONS) – (continued)8.3 Movement in deferred policy acquisition cost For the year ended 31 December 2020 Gross Reinsurance Net SR’000 SR’000 SR’000 Opening balance 14,157 - 14,157Incurred during the year 30,632 - 30,632Amortized during the year (13,130) - (13,130)Closing balance 31,659 - 31,659 For the year ended 31 December 20119 Gross Reinsurance Net SR’000 SR’000 SR’000 Opening balance 12,050 - 12,050Incurred during the year 25,288 - 25,288Amortized during the year (23,181) - (23,181)Closing balance 14,157 - 14,157 | 8 |
| Disclosure of gross outstanding claims/ benefits [text block] | 18. CLAIMS DEVELOPMENT TABLEThe following reflects the cumulative incurred claims, including both claims notified and incurred but not reported for each successive accident year at each statement of financial position date, together with the cumulative payments to date. The development of insurance liabilities provides a measure of the Company's ability to estimate the ultimate value of the claims.The Company aims to maintain adequate reserves in respect of its insurance business in order to protect against adverse future claims experience and developments. The IBNR estimate pertains to claims liability for the periods beginning from year 2014 and earlier onwards whose claim experience has not been fully developed. 18. CLAIMS DEVELOPMENT TABLE – (CONTINUED)Claims triangulation analysis is by accident years spanning a number of financial years.Claims development table gross of reinsurance:2020 Accident year or Underwriting year 2014 & Earlier 2015 2016 2017 2018 2019 2020 Total SR'000 SR'000 SR'000 SR'000 SR'000 SR'000 SR'000 SR'000Estimate of ultimate claims cost gross of reinsurance: At the end of accident year 321,511 287,332 351,010 267,868 331,435 387,920 344,741 2,291,817One year later 343,396 317,234 328,798 266,333 325,348 392,016 - 1,973,125Two years later 349,209 311,082 325,167 264,489 326,328 - - 1,576,275Three years later 350,195 317,782 325,018 265,417 - - - 1,258,412Four years later 351,991 316,809 326,144 - - - - 994,944Five years later 285,324 318,367 - - - - - 603,691Six years later 285,461 - - - - - - 285,461Current estimate of cumulative claims 285,461 318,367 326,144 265,417 326,328 392,016 344,741 2,258,474Cumulative payments to date (284,044) (316,718) (325,303) (263,353) (321,582) (379,786) (272,952) (2,163,738)Liability recognized in statement of financial position 1,417 1,649 841 2,064 4,746 12,230 71,789 94,736Salvage and subrogation 4 9 91 57 90 8,234 8,257 16,742Premium deficiency reserve - - - - - - 9,516 9,516Outstanding Claims and Reserves 1,340 1,591 592 658 1,626 (4,406) 24,693 26,094 18. CLAIMS DEVELOPMENT TABLE – (CONTINUED)2019 Accident year or Underwriting year 2013 & Earlier 2014 2015 2016 2017 2018 2019 Total SR'000 SR'000 SR'000 SR'000 SR'000 SR'000 SR'000 SR'000Estimate of ultimate claims cost gross of reinsurance: At the end of accident year 156,406 141,498 287,332 351,010 267,868 331,435 387,920 1,923,469One year later 180,014 157,746 317,234 328,798 266,333 325,348 - 1,575,473 Two years later 185,650 159,743 311,082 325,167 264,489 - - 1,246,131 Three years later 189,466 155,957 317,782 325,018 - - - 988,223Four years later 194,238 155,498 316,809 - - - - 666,545 Five years later 196,493 107,477 - - - - - 303,970 Six years later 177,847 - - - - - - 177,847 Current estimate of cumulative claims 177,847 107,477 316,809 325,018 264,489 325,348 387,920 1,904,908 Cumulative payments to date (176,488) (107,219) (315,178) (322,419) (260,754) (314,240) (312,698) (1,808,996) Liability recognized in statement of financial position 1,359 258 1,631 2,599 3,735 11,108 75,222 95,912 Salvage and subrogation - - 2 26 - 71 7,626 7,725 Premium deficiency reserve - - - - - 2,020 288 2,308 Outstanding Claims and Reserves 1,226 85 1,042 1,677 1,275 3,509 25,210 34,024 | 18 |
| Disclosure of accrued expenses and other liabilities [text block] | 14. ACCRUED AND OTHER PAYABLES 31 December 2020 31 December 2019 SR’000 SR’000 Accrued expenses 3,697 1,561Other payable 13,581 5,675Brokers payable 6,883 2,922VAT payable - 187Others 3 - 24,164 10,34515. SURPLUS DISTRIBUTION PAYABLE 31 December 2020 31 December 2019 SR’000 SR’000 Opening surplus distribution payable as at 1 January 5,982 5,457Total income attributed to the insurance operations during the year 456 525Surplus paid during the year (29) -Closing surplus distribution payable as at 31 December 6,409 5,982 | 14 |
| Disclosure of zakat [text block] | 20. ZAKAT AND INCOME TAXThe current year’s zakat provision is based on the following: 31 December 2020 31 December 2019 SR’000 SR’000 Equity 141,000 200,000Opening provisions and other adjustments 26,498 35,153Net book value of long term assets (5,314) (8,606)Accumulated losses 7,016 (55,469)Statutory deposit (30,000) -Unrealized loss on available for sale investments (49,259) (49,007) 89,941 122,071Adjusted income for the year 6,899 13,643Zakat base at 2.5% 2,319 135,714 31 December 2020 31 December 2019 SR’000 SR’000 Balance at the beginning of the year 8,453 5,086Provided during the year 4,463 5,396Payments during the year (1,941) (2,029)Balance at the end of the year 10,975 8,453The differences between the financial and the zakatable results are mainly due to certain adjustments in accordance with the relevant fiscal regulations.Zakat base has been computed based on the Company’s understanding of the Zakat regulations enforced in the Kingdom of Saudi Arabia. The Zakat regulations in Saudi Arabia are subject to different interpretations, and the assessments to be raised by the GAZT could be different from the declarations filed by the Company.Income tax:Foreign shareholder, being Islamic Development Bank (IDB) is exempted from income tax. 31 December 2020 31 December 2019 SR’000 SR’000 Balance at the beginning of the year 25 25Provided during the year - -Payments during the year - -Balance at the end of the year 25 25 22. ZAKAT AND INCOME TAX – (CONTINUED)Status of assessmentsZakat and income tax returns have been filed with the General Authority of Zakat and Tax (“GAZT”) for the years ended up to 31 December 2019. Final certificate has been received from GAZT for the year ended 31 December 2019. However, GAZT has raised an additional assessment in respect of the returns filed for the years ended 31 December 2008, 2009 and 2010 amounting to SR 1.86 million which has been paid. The major difference of additional assessment relates to disallowance of a portion of pre incorporation expenses and withholding tax. The Company has filed an objection against this additional assessment with the preliminary tax objection Committee subsequent to the year end, an adverse decision was received from the preliminary Tax Objection Committee, upon which the Company filed appeal with the Higher Objection Committee. The higher Objection Committee issued its decision in favour of the Company with respect to Zakat and rejected the appeal related to withholding tax. The Company has referred the matter to the Board of Grievance for the case of the withholding tax and raised a letter of guarantee in the amount of 1.83 million and also paid the amount of tax SAR 1.27 million. The Company has raised an objection for an unfavourable assessment raised by GAZT for the years ended 31 December 2013 till 2015 with the amount of SAR 4.98 million. The objection is currently under study by GAZT. The company received a claim from the GAZT for an amount of SAR 5.18 million representing withholding tax, the company raised an objection against the claim with the GSTC which has been also rejected and now is under appeal with the Appeal Committee for Tax Violation and Disputes.During the period ended 31 December 2020, GAZT issued an assessment for the years 2016 to 2018 claiming additional liability of 7.83 million. The Company has raised an objection against such assessments which has been rejected by GAZT. The company raised the objection to the GSTC and it is currently under study by the committee.Income tax:Islamic Development Bank (IDB) being a foreign shareholder, is exempted from income tax. | 22 |
| Disclosure of deferred tax [text block] | 25. VALUE ADDED TAX (VAT)On 28 September 2020, the Company received from The General Authority of Zakat and Tax (GAZT) VAT assessments for the years ended 31 December 2018 and 2019 claiming additional liability of SAR 1.78 million and SAR 1.98 million for VAT and SR 2.85 million and SR 1.78 million for related penalties, respectively. The Company has filled an objection against the said assessments and is confident of receiving a favourable outcome. However, as required by the GAZT regulation, the Company has paid the amount of the tax and was relieved from the penalties in accordance with GAZT initiative to support the private sector. | 25 |
| Disclosure of general and administrative expense [text block] | 27. GENERAL AND ADMINISTRATIVE EXPENSES 31 December 2020 31 December 2019 SR’000 SR’000 Employee costs 47,732 48,424Legal and professional fees 2,429 1,308Office rent - 2,547Depreciation and amortization 4,379 5,174Office expenses 2,215 2,473Marketing 9,978 10,461Traveling 481 951Other 6,639 8,595Audit Expense 584 466Share transfer – Tadawul expense 259 259Directors remuneration 1,863 1,460General Assembly Expense 32 79 76,591 82,197 | 22 |
| Disclosure of earnings per share [text block] | 22. (LOSS) / EARNINGS PER SHARE(Loss) / Earnings per share for the year has been calculated by dividing the net income for the year by the weighted average number of issued and outstanding shares for the year. The Company have reduced its share capital by offsetting with accumulated loss (note 23), as result the weighted average number of ordinary shares issued and outstanding in the prior year has been restated to 14.1 million and accordingly income per share is restated.A) The weighted average number of shares has been retrospectively adjusted for prior year to reflect the reduction in share capital as required by IAS 33 ‘’Earning per share” as follows: 31 December 2020 31 December 2019 (Restated) SR’000 SR’000 Issued and outstanding ordinary shares as at 1 January 20,000 20,000Effect of reduction of share capital (5,900) (5,900) Weighted average number of ordinary shares outstanding 14,100 14,100B) The basic and diluted profit per share is calculated as follows: 31 December 2020 31 December 2019 (Restated) SR’000 SR’000 Net (loss) / profit for the year (917) 1,719Weighted average number of ordinary shares outstanding 14,100 14,100 Basic and diluted earnings per share (SR) (0.07) 0.12 | 24 |
| Disclosure of related party transactions [text block] | 20. RELATED PARTY TRANSACTIONS AND BALANCESRelated parties represent major shareholders, directors and key management personnel of the Company, and companies of which they are principal owners and any other entities controlled, jointly controlled or significantly influenced by them. Pricing policies and terms of these transactions are approved by the Company’s management and Board of Directors. The following are the details of the major related party transactions during the period and the related balances:Relatedparty Nature of transaction Transactions for the year ended Closing balanceReceivables / (Payables) 31 December 2020 31 December 2019 31 December 2020 31 December 2019 SR’000 SR’000 SR’000 SR’000 Board of directors Premium written 360 797 1,882 2,239 Claim paid / payment received (811) (3,652) (881) (450) ACIG Bahrain (Shareholder) Claims paid on behalf of ACIG Bahrain 225 - 1,985 1,760 Board and audit committee Attendance fees 1,405 1,471 - -Remuneration and compensation of BOD Members and Top Executives (Disclose number of top executives)2020 BOD members (Non-Executive) Top Executives including the CEO and CFO SR’000 SR’000Salaries and compensation - 5,504Allowances 198 -Annual remuneration 1,050 120End of service indemnities - 410Total 1,248 6,0342019 BOD members (Non-Executive) Top Executives including the CEO and CFO SR’000 SR’000Salaries and compensation - 5,467Allowances 176 -Annual remuneration 1,290 120End of service indemnities - 410Total 1,466 5,997 | 21 |
| Disclosure of entity's operating segments [text block] |
SEGMENTAL INFORMATION – (continued)
These unallocated assets and liabilities are not reported to chief operating decision maker under related segments and are monitored on a centralized basis.
The segment information provided to the Company’s Board of Directors for the reportable segments for the Company’s total assets and liabilities at 31 December 2020 and 31 December 2019, its total revenues, expenses, and net income for the year then ended, are as follows: OPERATING SEGMENTS | Medical | Motor | General Accident | Others | Total - Insurance operations | Share- holders operations | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | ASSETS |
|
|
|
|
|
|
| Cash and cash equivalents | - | - | - | - | 72,725 | 75,251 | 147,976 | | Term Deposits | - | - | - | - | 119,331 | - | 119,331 | | Premiums and reinsurers’ receivable, net | - | - | - | - | 98,638 | - | 98,638 | | Reinsurers’ share of unearned premiums | 13,733 | - | 5,085 | 8,575 | 27,393 | - | 27,393 | | Reinsurers’ share of outstanding claims | 4,564 | 3,399 | 2,592 | 1,353 | 11,908 | - | 11,908 | | Reinsurers’ share of claims incurred but not reported | 6,683 | - | 614 | 723 | 8,020 | - | 8,020 | | Deferred policy acquisition costs | 3,637 | 26,943 | 672 | 407 | 31,659 | - | 31,659 | | Unallocated assets | - | - | - | - | 77,348 | 85,137 | 162,485 | | TOTAL ASSETS | 28,617 | 30,342 | 8,963 | 11,058 | 447,022 | 160,388 | 607,410 | |
|
|
|
|
|
|
|
| | LIABILITIES |
|
|
|
|
|
|
| | Policyholders claims payable | - | - | - | - | 10,142 | - | 10,142 | | Reinsurance balances payable | - | - | - | - | 16,661 | - | 16,661 | | Unearned reinsurance commission | - | - | 467 | 959 | 1,426 | - | 1,426 | | Unearned premiums | 65,369 | 172,480 | 17,261 | 9,359 | 264,469 | - | 264,469 | | Premium deficiency reserves | 5,060 | 4,456 | - | - | 9,516 | - | 9,516 | | Other technical reserves | 356 | 1,776 | 309 | 41 | 2,482 | - | 2,482 | | Outstanding claims | 15,226 | 1,983 | 8,466 | 419 | 26,094 | - | 26,094 | | Claims incurred but not reported | 22,292 | 42,258 | 3,296 | 797 | 68,643 | - | 68,643 | | Unallocated liabilities and equity | - | - | - | - | 47,589 | 160,388 | 207,977 | | TOTAL LIABILITIES AND EQUITY | 108,303 | 222,953 | 29,799 | 11,575 | 447,022 | 160,388 | 607,410 | |
SEGMENTAL INFORMATION – (continued)
OPERATING SEGMENTS | Medical | Motor | General Accident |
Others | Total - Insurance operations | Share-holders operations | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | ASSETS |
|
|
|
|
|
|
| Cash and cash equivalents | - | - | - | - | 65,320 | 12,159 | 77,479 | Term Deposits | - | - | - | - | 138,920 | 55,663 | 194,583 | Premiums and reinsurers’ receivable, net | - | - | - | - | 88,140 | - | 88,140 | Reinsurers’ share of unearned premiums | 11,952 | - | 5,111 | 4,260 | 21,323 | - | 21,323 | Reinsurers’ share of outstanding claims | 4,640 | 2,869 | 1,731 | 478 | 9,718 | - | 9,718 | Reinsurers’ share of claims incurred but not reported | 5,053 | - | 667 | 877 | 6,597 | - | 6,597 | Deferred policy acquisition costs | 4,407 | 8,478 | 733 | 539 | 14,157 | - | 14,157 | Unallocated assets | - | - | - | - | 63,863 | 86,970 | 150,833 | TOTAL ASSETS | 26,052 | 11,347 | 8,242 | 6,154 | 408,038 | 154,792 | 562,830 |
|
|
|
|
|
|
|
| LIABILITIES |
|
|
|
|
|
|
| Policyholders claims payable | - | - | - | - | 1,506 | - | 1,506 | Reinsurance balances payable | - | - | - | - | 16,470 | - | 16,470 | Unearned reinsurance commission | - | - | 450 | 889 | 1,339 | - | 1,339 | Unearned premiums | 56,922 | 177,232 | 15,023 | 5,183 | 254,360 | - | 254,360 | Premium deficiency reserves | 2,308 | - | - | - | 2,308 | - | 2,308 | Other technical reserves | 171 | 1,322 | 183 | 40 | 1,716 | - | 1,716 | Outstanding claims | 16,303 | 12,309 | 4,776 | 636 | 34,024 | - | 34,024 | Claims incurred but not reported | 17,790 | 40,587 | 2,552 | 958 | 61,887 | - | 61,887 | Unallocated liabilities and equity | - | - | - | - | 34,428 | 154,792 | 189,220 | TOTAL LIABILITIES AND EQUITY | 93,494 | 231,450 | 22,984 | 7,706 | 408,038 | 154,792 | 562,830 |
SEGMENTAL INFORMATION – (continued)
| For the year ended 31 December, 2020 |
OPERATING SEGMENTS | Medical | Motor | General Accident | Others | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | REVENUES |
|
|
|
|
|
|
|
|
|
|
| Gross premiums written | 126,709 | 339,228 | 19,316 | 29,864 | 515,117 | Reinsurance premiums ceded |
|
|
|
|
| -Local | (2,628) | - | (86) | (1,382) | (4,096) | -Foreign | (23,804) | - | (7,093) | (26,140) | (57,037) |
| (26,432) | - | (7,179) | (27,522) | (61,133) | Excess of loss premiums |
|
|
|
|
| -Local | - | (1,474) | (684) | (186) | (2,344) | -Foreign | - | (2,212) | 309 | (277) | (2,180) |
| - | (3,686) | (375) | (463) | (4,524) |
|
|
|
|
|
| NET WRITTEN PREMIUMS | 100,277 | 335,542 | 11,762 | 1,879 | 449,460 | Changes in net unearned premiums | (6,666) | 4,751 | (2,264) | 140 | (4,039) | NET PREMIUMS EARNED | 93,611 | 340,293 | 9,498 | 2,019 | 445,421 | Reinsurance commission earned | - | - | 747 | 3,365 | 4,112 | Other underwriting income | 2,253 | 1,816 | 2,191 | - | 6,260 | NET REVENUES | 95,864 | 342,109 | 12,436 | 5,384 | 455,793 |
|
|
|
|
|
| UNDERWRITING COSTS AND EXPENSES |
|
|
|
|
| Gross claims paid | 123,282 | 256,486 | 2,415 | 659 | 382,842 | Reinsurers’ share of claims paid | (35,504) | (1,630) | (613) | (376) | (38,123) | NET CLAIMS PAID | 87,778 | 254,856 | 1,802 | 283 | 344,719 | Changes in outstanding claims, net | (1,000) | (10,856) | 1,806 | (70) | (10,120) | Changes in claims incurred but not reported, net | 2,872 | 1,671 | 796 | (6) | 5,333 | NET CLAIMS INCURRED | 89,650 | 245,671 | 4,404 | 207 | 339,932 | Change in other technical reserve | 185 | 453 | 126 | 2 | 766 | Changes in premium deficiency reserve | 2,752 | 4,455 | - | - | 7,207 | Policy acquisition costs | 8,335 | 20,173 | 756 | 1,368 | 30,632 | Other underwriting expenses | 258 | 5,475 | - | - | 5,733 | TOTAL UNDERWRITING COSTS AND EXPENSES | 101,180 | 276,227 | 5,286 | 1,577 | 384,270 |
|
|
|
|
|
| NET UNDERWRITING RESULTS | (5,316) | 65,882 | 7,150 | 3,807 | 71,523 |
|
|
|
|
|
| OTHER OPERATING (EXPENSES)/ INCOME |
|
|
|
|
| Release of doubtful debts |
|
|
|
| 4,354 | General and administrative expenses |
|
|
|
| (76,591) | Commission income on deposits |
|
|
|
| 2,648 | Investment income |
|
|
|
| 2,056 | Other income |
|
|
|
| 12 | TOTAL OTHER OPERATING (EXPENSES) / INCOME |
|
|
|
| (67,521) |
|
|
|
|
|
| Total income for the year |
|
|
|
| 4,002 | Zakat charge for the year |
|
|
|
| (4,463) |
|
|
|
|
|
| NET LOSS FOR THE YEAR |
|
|
|
| (461) | NET INCOME ATTRIBUTED TO THE INSURANCE OPERATIONS |
|
|
|
| (456) | NET LOSS ATTRIBUTABLE TO THE SHAREHOLDERS |
|
|
|
| (917) |
SEGMENTAL INFORMATION – (continued)
| For the year ended 31 December, 2019 |
OPERATING SEGMENTS | Medical | Motor | General Accident | Others | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 |
|
|
|
|
|
| REVENUES |
|
|
|
|
| Gross premiums written | 139,035 | 354,693 | 15,902 | 19,722 | 529,352 | Reinsurance premiums ceded |
|
|
|
|
| -Local | (2,659) | - | (126) | (1,701) | (4,486) | -Foreign | (25,641) | - | (8,330) | (15,745) | (49,716) |
| (28,300) |
| (8,456) | (17,446) | (54,202) | Excess of loss premiums |
|
|
|
|
| -Local | - | (1,263) | (220) | (230) | (1,713) | -Foreign | - | (1,895) | (331) | (344) | (2,570) |
| - | (3,158) | (551) | (574) | (4,283) |
|
|
|
|
|
| NET WRITTEN PREMIUMS | 110,735 | 351,535 | 6,895 | 1,702 | 470,867 | Changes in net unearned premiums | 7,213 | (12,722) | 2,129 | (388) | (3,768) | NET PREMIUMS EARNED | 117,948 | 338,813 | 9,024 | 1,314 | 467,099 | Reinsurance commission earned | - | 6 | 754 | 2,991 | 3,751 | Other underwriting income | - | 2,251 | - | - | 2,251 | NET REVENUES | 117,948 | 341,070 | 9,778 | 4,305 | 473,101 |
|
|
|
|
|
| UNDERWRITING COSTS AND EXPENSES |
|
|
|
|
| Gross claims paid | 132,301 | 263,258 | 3,430 | 693 | 399,682 | Reinsurers’ share of claims paid | (31,371) | (2,594) | (1,829) | (536) | (36,330) | NET CLAIMS PAID | 100,930 | 260,664 | 1,601 | 157 | 363,352 | Changes in outstanding claims, net | (2,720) | (5,214) | 382 | (17) | (7,569) | Changes in claims incurred but not reported, net | 1,153 | 3,789 | 617 | (34) | 5,525 | NET CLAIMS INCURRED | 99,363 | 259,239 | 2,600 | 106 | 361,308 | Change in other technical reserve | 3 | (49) | (17) | (17) | (80) | Changes in premium deficiency reserve | 288 | - | - | - | 288 | Policy acquisition costs | 9,736 | 13,388 | 893 | 1,271 | 25,288 | Other underwriting expenses | 1,455 | 4,494 | - | - | 5,949 | TOTAL UNDERWRITING COSTS AND EXPENSES | 110,845 | 277,072 | 3,476 | 1,360 | 392,753 |
|
|
|
|
|
| NET UNDERWRITING RESULTS | 7,103 | 63,998 | 6,302 | 2,945 | 80,348 |
|
|
|
|
|
| OTHER OPERATING (EXPENSES) / INCOME |
|
|
|
|
| Release of doubtful debts |
|
|
|
| 227 | General and administrative expenses |
|
|
|
| (82,197) | Realized gain on available-for-sale investments |
|
|
|
| 6,174 | Investment income |
|
|
|
| 3,063 | Other income |
|
|
|
| 25 | TOTAL OTHER OPERATING (EXPENSES) / INCOME |
|
|
|
| (72,708) |
|
|
|
|
|
| Total income for the year |
|
|
|
| 7,640 | Zakat charge for the year |
|
|
|
| (5,396) | NET LOSS FOR THE YEAR |
|
|
|
| 2,244 | NET INCOME ATTRIBUTED TO THE INSURANCE OPERATIONS |
|
|
|
| (525) | NET LOSS ATTRIBUTABLE TO THE SHAREHOLDERS |
|
|
|
| 1,719 |
SEGMENTAL INFORMATION – (continued)
| For the year ended December 31, 2020 |
| Medical | Motor | Properties and accident | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | Gross written premium |
|
|
|
| Retail | 6,812 | 332,415 | 10,162 | 349,389 | Micro | 37,076 | 4,277 | 446 | 41,799 | Small | 50,318 | 1,369 | 2,748 | 54,435 | Medium | 14,291 | 1,167 | 6,650 | 22,108 | Large | 18,212 | - | 29,174 | 47,386 | Total | 126,709 | 339,228 | 49,180 | 515,117 |
| For the year ended December 31, 2019 |
| Medical | Motor | Properties and accident | Total |
| SR’000 | SR’000 | SR’000 | SR’000 | Gross written premium |
|
|
|
| Retail | 12,562 | 343,350 | 6,051 | 361,963 | Micro | 11,368 | 1,181 | 679 | 13,228 | Small | 39,723 | 4,765 | 6,897 | 51,385 | Medium | 24,807 | 1,840 | 4,657 | 31,304 | Large | 50,575 | 3,557 | 17,340 | 71,472 | Total | 139,035 | 354,693 | 35,624 | 529,352 |
| 20 |
| Disclosure of capital management [text block] | 22. SHARE CAPITAL AS at 31 December 2019, the authorized, subscribed and paid up share capital of the Company was SR 200 million, divided into 20 million shares of SR 10 each.On 16 January 2020, the Company’s board of directors had recommended reducing the Company’s share capital from SR 200 million to SR 141 million divided into 5.9 million share by off-setting with accumulated losses. In an extra-ordinary general meeting held on 21 Muharram 1441H corresponding to 26 August 2020, the shareholders’ of the Company approved the reduction and the required changes in the Company by-law relating to the reduction. Accordingly, the share capital and accumulated losses have been reduced to SR 141 million. The capital reduction is through the reduction of 1 share for every 3.3898 shares held by the shareholders. The purpose of capital reduction is to restructure the capital position of the Company in order to comply with the Companies Law. There is no impact of reduction in capital on the Company’s financial obligations.As at 31 December 2020, the authorized, subscribed and paid up share capital of the Company is SR 141 million, divided in to 14.1 million share of 10 each.On 21 Jamad Al-Awwal 1441H corresponding to 16 January 2020, the Board of Directors had recommended an increased in the Company’s capital through right issue with a total value of SR 150 million, on 14 Safar 1442H corresponding to 1 October 2020, the Company obtained approval from SAMA. As of the date of approval of these financial statements, the Company is currently in the process of completing the remaining regulatory and legal formalities underlying such increase. | 23 |
| Disclosure of risk management [abstract] | | |
| Disclosure of insurance/ takaful risk [text block] |
MANAGEMENT
(a)Insurance
The principal risk the Company faces under insurance contracts is that the actual claims and benefit payments or the timing thereof, differ from expectations. This is influenced by the frequency of claims, severity of claims, actual benefits paid and subsequent development of long–term claims. Therefore, the objective of the Company is to ensure that sufficient reserves are available to cover these liabilities.
The Company purchases reinsurance as part of its risks mitigation programme. Reinsurance ceded is placed on both a proportional and non–proportional basis. The majority of proportional reinsurance is quota–share reinsurance which is taken out to reduce the overall exposure of the Company to certain classes of business. Non–proportional reinsurance is primarily excess–of–loss reinsurance designed to mitigate the Company’s net exposure to catastrophe losses. Retention limits for the excess–of–loss reinsurance vary by product line and territory.
Amounts recoverable from reinsurers are estimated in a manner consistent with the outstanding claims provision and are in accordance with the reinsurance contracts. Although the Company has reinsurance arrangements, it is not relieved of its direct obligations to its policyholders and thus a credit exposure exists with respect to reinsurance ceded, to the extent that any reinsurer is unable to meet its obligations assumed under such reinsurance arrangements. The Company’s placement of reinsurance is diversified such that it is neither dependent on a single reinsurer nor are the operations of the Company substantially dependent upon any single reinsurance contract. There is no single counterparty exposure that exceeds 36% of total reinsurance assets at the reporting date.
Frequency and severity of claims
The frequency and severity of claims can be affected by several factors like natural disasters, flood, environmental and economical, atmospheric disturbances, concentration of risks, civil riots etc. The Company manages these risk through the measures described above. The company has limited its risk by imposing maximum claim amounts on certain contracts as well as the use of reinsurance arrangements in order to limit exposure to catastrophic events (e.g., hurricanes, earthquakes and flood damage). The purpose of these underwriting and reinsurance strategies is to limit exposure to catastrophes based on the Company’s risk appetite as decided by management. The overall aim is currently to restrict the impact of a single catastrophic event to approximately 15% of shareholders’ equity on a gross basis and 3% on a net basis. In the event of such a catastrophe, counterparty exposure to a single reinsurer is estimated not to exceed 5% of shareholders’ equity. The Board may decide to increase or decrease the maximum tolerances based on market conditions and other factors.
Concentration of insurance risk
The Company monitors concentration of insurance risks primarily by class of business. The major concentration lies in medical segment.
The Company also monitors concentration of risk by evaluating multiple risks covered in the same geographical location. For flood or earthquake risk, a complete city is classified as a single location. For fire and property risk a particular building and neighboring buildings, which could be affected by a single claim incident, are considered as a single location. Similarly, for marine risk, multiple risks covered in a single vessel voyage are considered as a single risk while assessing concentration of risk. The Company evaluates the concentration of exposures to individual and cumulative insurance risks and establishes its reinsurance policy to reduce such exposures to levels acceptable to the Company.
Since the Company operates majorly in Saudi Arabia, hence, all the insurance risks relate to policies written in Saudi Arabia
RISK MANAGEMENT – (continued)
Sources of uncertainty in estimation of future claim payments
The key source of estimation uncertainty at the statement of financial position date relates to valuation of outstanding claims, whether reported or not, and includes expected claims settlement costs. Claims are payable to Policyholders and third parties depending upon the terms of the contract as contained in policy terms and conditions. The principal assumption underlying the liability estimates is that the Company’s future claims development will follow a similar pattern to past claims development experience. This includes assumptions in respect of average claim costs, claim handling costs, claim inflation factors and claim numbers for each accident year. Additional qualitative judgements are used to assess the extent to which past trends may not apply in the future, for example: one–off occurrence; changes in market factors such as public attitude to claiming: economic conditions: as well as internal factors such as portfolio mix, policy conditions and claims handling procedures. Judgement is further used to assess the extent to which external factors such as judicial decisions and government legislation affect the estimates.
Considerable judgment by management is required in the estimation of amounts due to policyholders arising from claims made under insurance contracts. Such estimates are necessarily based on assumptions about several factors involving varying and possibly significant degrees of judgment and uncertainty and actual results may differ from management’s estimates resulting in future changes in estimated liabilities. Qualitative judgments are used to assess the extent to which past trends may not apply in the future, for example one-off occurrence, changes in market factors such as public attitude to claiming and economic conditions. Judgment is further used to assess the extent to which external factors such as judicial decisions and government legislation affect the estimates.
In particular, estimates have to be made both for the expected ultimate cost of claims reported at the statement of financial position date and for the expected ultimate cost of claims incurred but not reported (IBNR) at the statement of financial position date.
Process used to decide on assumptions
The process used to determine the assumptions for calculating the outstanding claim reserve is intended to result in neutral reasonable estimates of the most likely or expected outcome. The nature of the business makes it very difficult to predict with certainty the likely outcome of any particular claim and the ultimate cost of notified claims. Each notified claim is assessed on a separate, case by case basis with due regard to claim circumstances, information available from surveyors and historical evidence of the size of similar claims. Case estimates are reviewed regularly and are updated as and when new information is available.
The estimation of IBNR is generally subject to a greater degree of uncertainty than the estimation of the cost of settling claims already notified to the Company, in which case information about the claim event is available. The estimation process takes into account the past claims reporting pattern and details of reinsurance programs.
The ultimate cost of outstanding claims is estimated by using a range of standard actuarial claims projection techniques, such as Chain Ladder and Bornheutter-Ferguson methods.
The main assumption underlying these techniques is that a Company’s past claims development experience can be used to project future claims development and hence ultimate claims costs. As such, these methods extrapolate the development of paid and incurred losses, average costs per claim and claim numbers based on the observed development of earlier years and expected loss ratios. Historical claims development is mainly analysed by accident years, but can also be further analysed by geographical area, as well as by significant business lines and claim types. Large claims are usually separately addressed, either by being reserved at the face value of loss adjuster estimates or separately projected in order to reflect their future development. In most cases, no explicit assumptions are made regarding future rates of claims inflation or loss ratios. Instead, the assumptions used are those implicit in the historical claims development data on which the projections are based. Additional qualitative judgement is used to assess the extent to which past trends may not apply in future, (e.g., to reflect one-off occurrences, changes in external or market factors such as public attitudes to claiming, economic conditions, levels of claims inflation, judicial decisions and legislation, as well as internal factors such as portfolio mix, policy features and claims handling procedures) in order to arrive at the estimated ultimate cost of claims that present the likely outcome from the range of possible outcomes, taking account of all the uncertainties involved.
RISK MANAGEMENT – (continued)
Process used to decide on assumptions – (continued)
The premium liabilities have been determined such that the total premium liability provisions (unearned premium reserve and premium deficiency reserve in result of liability adequacy test) would be sufficient to service the future expected claims and expenses likely to occur on the unexpired policies as at the statement of financial position date. The expected future liability is determined using estimates and assumptions based on the experience during the expired period of the contracts and expectations of future events that are believed to be reasonable.
Sensitivity analysis
The Company believes that the estimated claim liabilities under insurance contracts disclosed in the financial statements outstanding at the year-end are considered to be adequate. However, these amounts are not certain and actual payments may differ from the claims liabilities provided in the financial statements. The insurance claim liabilities are sensitive to the various assumptions. It has not been possible to quantify the sensitivity of specific variable such as legislative changes or uncertainty in the estimation process.
A hypothetical 2% change in the claim ratio, net of reinsurance, would impact net underwriting income/ (loss) as follows;
Income from insurance operations | 31 December 2020 | 31 December 2019 |
| SR’000 | SR’000 | Impact of change in claim ratio by - 2% |
|
| Medical | (3,444) | 9,462 | Motor | 72,688 | 70,774 | General Accident | 7,340 | 6,482 | Others | 3,846 | 2,971 |
|
|
|
| 80,430 | 89,689 |
Income from insurance operations | 31 December 2020 | 31 December 2019 |
| SR’000 | SR’000 | Impact of change in claim ratio by + 10% |
|
| Medical | (14,677) | 4,744 | Motor | 31,852 | 57,222 | General Accident | 6,200 | 6,122 | Others | 3,604 | 2,919 |
|
|
|
| 26,980 | 71,007 |
(a)Reinsurance risk
In order to limit the financial exposure arising from large claims, the Company, in the normal course of business, enters into agreements with other parties for reinsuring its exposures.
To minimize its exposure to significant losses from reinsurer insolvencies, the Company evaluates the financial condition of its reinsurers and monitors concentrations of credit risk arising from similar geographic regions, activities or economic characteristics of the reinsurers.
Reinsurers are selected using the following parameters and guidelines set by the Company’s Board of Directors. The criteria may be summarized as follows:
RISK MANAGEMENT – (continued)
(a)Reinsurance risk – (continued)
-Minimum acceptable credit rating by recognized rating agencies (e.g. S&P) that is not lower than BBB or equivalent -Reputation of particular reinsurance companies -Existing or past business relationship with the reinsurer.
Furthermore, the financial strength and managerial and technical expertise as well as historical performance of the reinsurers, wherever applicable, are thoroughly reviewed by the Company and agreed to pre-set requirements of the Company’s Board of Directors before approving them for exchange of reinsurance business. As at 31 December 2019 and 2018, there is no significant concentration of reinsurance balances.
Reinsurance ceded contracts do not relieve the Company from its obligations to policyholders and as a result the Company remains liable for the portion of outstanding claims reinsured to the extent that the reinsurer fails to meet the obligations under the reinsurance agreements.
(b)Market Risk
Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risk comprises three types of risk: foreign exchange rates (currency risk), market interest rates (interest rate risk) and market prices (price risk).
-The Company’s market risk policy sets out the assessment and determination of what constitutes market risk for the Company. Compliance with the policy is monitored and exposures and breaches are reported to the Company’s Board Investment Committee and Risk committee. The policy is reviewed regularly for pertinence and for changes in the risk environment. -Guidelines are set for asset allocation and portfolio limit structure, to ensure that assets back specific policyholders’ liabilities and that assets are held to deliver income and gains for policyholders and shareholders which are in line with their expectations. -The Company stipulates diversification benchmarks by type of instrument and geographical area, as the Company is exposed to guaranteed bonuses, cash and annuity options when interest rates fall. -There is strict control over hedging activities (e.g., equity derivatives are only permitted to be held to facilitate portfolio management or to reduce investment risk).
The Board of Directors of the Company ensure that the overall market risk exposure is maintained at prudent levels and is consistent with the available capital. While the Board gives a strategic direction and goals, risk management function related to market risk is mainly the responsibility of Investment Committee team. The team prepares forecasts showing the effects of various possible changes in market conditions related to risk exposures. This risk is being mitigated through the proper selection of securities. Company maintains diversified portfolio and performs regular monitoring of developments in related markets. In addition, the key factors that affect stock and sukuk market movements are monitored, including analysis of the operational and financial performance of investees.
Market risk comprises of three types of risk: currency risk, commission rate risk and other price risk.
Currency Risk
Currency risk is the risk that the value of a financial instrument will fluctuate due to changes in foreign exchange rates.
The Company’s transactions are principally in Saudi Arabian Riyals. So that the foreign currency risk is not significant.
RISK MANAGEMENT – (continued)
Commission Rate Risk
The Company invests in securities and has deposits that are subject to commission rate risk. Commission rate risk to the Company is the risk of changes in commission rates reducing the overall return on its fixed commission rate bearing securities. The Commission rate risk is limited by monitoring changes in commission rates and by investing in floating rate instruments.
An increase or decrease of 50 basis points in interest yields would result in a change in the income for the year of SAR 1.1 million (2019: SAR 1.1 million).
The commission bearing investments of the Company and their maturities as at December 31, 2020 and 2019 are as follows:
| Less than 1 year | More than 1 year | Total |
| SR’000 | SR’000 | SR’000 | Insurance Operations |
|
|
| 2020 | 119,331 | - | 119,331 | 2019 | 138,920 | - | 138,920 |
|
|
|
| Shareholders Operations |
|
|
| 2020 | 61,050 | 20,000 | 81,050 | 2019 | 55,663 | 25,000 | 80,663 |
Other Price Risk
Other price risk is the risk that the fair value or future cash flows of financial instruments will fluctuate because of changes in market prices (other than those arising from commission rate risk or currency risk), whether those changes are caused by factors specific to the individual financial instrument or its issuer, or factors affecting all similar financial instruments traded in the market.
The Company's investments amounting to SAR 27.3 million (2019: SAR 24.2 million) are susceptible to market price risk arising from uncertainty about the future value of invested securities. The Company limits this nature of market risk by diversifying its invested portfolio and by actively monitoring the developments in markets.
The impact of hypothetical change of a 10% increase and 10% decrease in the market prices of investments on Company's profit would be as follows:
| Fair value change | Effect on Company’s profit |
| SR’000 | SR’000 | 31 December 2020 | + / - 10% | +/- 2,734 | 31 December 2019 | + / - 10% | +/- 2,420 |
The sensitivity analysis presented is based upon the portfolio position as at 31 December 2020 and 2019. Accordingly, the sensitivity analysis prepared is not necessarily indicative of the effect on the Company's assets of future movements in the value of investments held by the Company.
RISK MANAGEMENT – (continued)
(c)Credit Risk
Credit risk is the risk that one party to a financial instrument will fail to discharge an obligation and cause the other party to incur a financial loss. For all classes of financial instruments held by the Company, the maximum credit risk exposure to the Company is the carrying value as disclosed in the statement of financial position.
The table below shows the maximum exposure to credit risk for the relevant components of the statement of financial position:
| 2020 | 2019 |
| SR’000 | SR’000 | ASSETS - INSURANCE OPERATIONS |
|
| Cash and cash equivalents | 53,559 | 65,320 | Premiums and reinsurers’ receivable – net | 98,638 | 88,140 | Reinsurers’ share of outstanding claims | 11,908 | 9,718 | Reinsurers’ share of claims incurred but not reported | 8,020 | 6,597 | Prepayments and other receivables | 60,076 | 46,270 | Total | 232,201 | 216,045 |
| 2020 | 2019 |
| SR’000 | SR’000 | ASSETS - SHAREHOLDERS’ OPERATIONS |
|
| Cash and cash equivalents | 14,201 | 12,159 | Available-for-sale investments | 49,259 | 51,106 | Total | 63,460 | 63,265 |
Concentration of credit risk
Concentration of credit risk exists when changes in economic or industry factors similarly affect groups of counterparties whose aggregate credit exposure is significant in relation to the Company’s total credit exposure. Approximately 100% (2019: approximately 100%) of the Company’s underwriting activities are carried out in Saudi Arabia. The Company’s portfolio of financial instruments is broadly diversified and transactions are entered into with diverse credit-worthy counterparties thereby mitigating any significant concentrations of credit risk.
Credit risk exposure
| 2020 | 2019 | 2020 | 2019 | 2020 | 2019 |
| SR’000 | SR’000 | SR’000 | SR’000 | SR’000 | SR’000 |
| Investment grade | Non-investment grade | Unrated |
Investments: |
|
|
|
|
|
| - Available for sale |
|
|
|
|
|
| Debt instruments | - | - | 20,000 | 25,000 | - | - | Equities | 11,177 | 11,256 | - | - | - | - | Other | 16,159 | 12,927 | - | - | 1,923 | 1,923 | Premium and reinsurance balances receivable |
|
|
|
|
|
| Policyholders’ | - | - | - | - | 93,309 | 83,154 | Due from a related party | - | - | - | - | 1,985 | 1,760 | Reinsurance receivables | - | - | - | - | 5,329 | 4,986 | Total | 27,336 | 24,183 | 20,000 | 25,000 | 102,546 | 91,823 |
To manage the liquidity risk arising from financial liabilities mentioned above, the Company holds liquid assets comprising cash and cash equivalents and investment securities. These assets can be readily sold to meet liquidity requirements.
The assets with maturity less than one year are expected to realize as follows: Deposits are expected to be matured within 6 months from the date of placement. Cash and bank balances are available on demand.
RISK MANAGEMENT – (continued)
(d)Liquidity Risk - (continued)
Reinsurers share of outstanding claims majorly pertain to property and casualty segment and are generally realized within 6 to 12 months based on settlement of balances with reinsurers.
The liabilities with maturity less than one year are expected to settle as follows: Reinsurers’ balances payable are settled on a quarterly basis as per terms of reinsurance agreements. As per the Regulation, all insurance claims need to be settled within the time limits specified in this regard. Majority of gross outstanding claims are expected to be settled within the time limits set in this regard subject to meeting all the documentation requirements. Property and casualty policies due to the inherent nature are generally settled within 45 days from the date of receipt of loss adjustor report The claims payable, accrued expenses and other liabilities are expected to settle within a period of 1-3 months from the period end date. Surplus distribution payable is to be settled within 6 months of annual general meeting in which financial statements are approved.
(e)Operational Risk
Operational risk is the risk of direct or indirect loss arising from a wide variety of causes associated with the processes, technology and infrastructure supporting the Company’s operations either internally within the Company or externally at the Company’s service providers, and from external factors other than credit, market and liquidity risks such as those arising from legal and regulatory requirements and generally accepted standards of investment management behavior. Operational risks arise from all of the Company’s activities.
The Company’s objective is to manage operational risk so as to balance limiting of financial losses and damage to its reputation with achieving its investment objective of generating returns for investors. The primary responsibility for the development and implementation of controls over operational risk rests with the Board of Directors. This responsibility encompasses the controls in the following areas:
-Requirements for appropriate segregation of duties between various functions, roles and responsibilities; -Requirements for the reconciliation and monitoring of transactions; -Compliance with regulatory and other legal requirements; -Documentation of controls and procedures; -Requirements for the periodic assessment of operational risks faced, and the adequacy of controls and procedures to address the risks identified; -Ethical and business standards; and -Risk mitigation policies and procedures.
Senior Management ensures that the Company's staff has adequate training and experience and fosters effective communication related to operational risk management.
| 28 |
| Disclosure of fair value of financial assets and liabilities [text block] | 19. FAIR VALUE OF FINANCIAL INSTRUMENTSFair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction takes place either:- in the accessible principal market for the asset or liability, or- in the absence of a principal market, in the mostThe management assessed that cash and short-term deposits, receivables from related parties, loans to related parties, trade and other payables, bank overdrafts, variable rate loans and other financial liabilities approximate their carrying amounts largely due to the short-term maturities of these instruments.Determination of fair value and fair value hierarchyThe Company uses the following hierarchy for determining and disclosing the fair value of financial instruments:Level 1: quoted prices in active markets for the same or identical instrument that an entity can access at the measurement date;Level 2: quoted prices in active markets for similar assets and liabilities or other valuation techniques for which all significant inputs are based on observable market data; andLevel 3: valuation techniques for which any significant input is not based on observable market data.During the year ended 31 December 2020, there were no transfers between Level 1 and Level 2 fair value measurements, and no transfers into or out of level 3 fair value measurementsa. Carrying amounts and fair valueThe following table shows the carrying amount and fair values of financial assets and financial liabilities, including their levels in the fair value hierarchy for financial instruments measured at fair value. Fair value Carrying value Level 1 Level 2 Level 3 Total SR’000 SR’000 SR’000 SR’000 SR’00031 December 2020 - Available for sale investments Debt instrument 20,000 - 20,000 - 20,000Equities 13,100 11,177 - 1,923- 13,100Other 16,159 16,159 - - 16,159 49,259 27,336 20,000 1,923 49,259 Fair value Carrying value Level 1 Level 2 Level 3 Total SR’000 SR’000 SR’000 SR’000 SR’00031 December 2019 - Available for sale investments Debt instrument 25,000 - 25,000 - 25,000Equities 11,256 11,256 - - 11,256Other 14,850 12,927 - 1,923 14,850 51,106 24,183 25,000 1,923 51,106 19. FAIR VALUE OF FINANCIAL INSTRUMENTS – (continued)b. Valuation technique and significant unobservable inputsThe following table shows the valuation techniques used in measuring Level 2 and Level 3 fair values at 31 December 2020 and 31 December 2019, as well as the significant unobservable inputs used.Type Valuation technique Significant unobservable inputs Inter-relationship between significant unobservable inputs and fair value measurementAvailable for sale equity securities (unquoted)/ Investments held as FVSI (unquoted) Market comparison technique:The valuation model is based on market multiples derived from quoted prices of companies comparable to investe0e and the expected EBITDA of the investee. This estimate is adjusted for the effect of non-marketability of the equity securities. Forecast annual revenue growth rate Forecast EBITDA margin Adjusted market multiple The estimated fair value would increase (decrease) if: The annual revenue growth rate were higher (lower); The EBITDA margin were higher (lower); or The adjusted market multiple were lower (higher).Generally, a change in the annual revenue growth is accompanied by a directionally similar change in EBITDA margin.Corporate debt securities / Held to maturity investments Market comparison technique:The fair values are based on broker quotes. Similar contracts are traded in an active market and the quotes reflect the actual transactions in similar instruments. Not applicable. Not applicable.20. SEGMENTAL INFORMATION Operating segments are identified on the basis of internal reports about components of the Company that are regularly reviewed by the Company’s Board of Directors in their function as chief operating decision maker in order to allocate resources to the segments and to assess its performance.Transactions between the operating segments are on normal commercial terms and conditions. The revenue from external parties reported to the Board is measured in a manner consistent with that in the income statement. Segment assets and liabilities comprise operating assets and liabilities.Segment results do not include general and administrative expenses, provision for doubtful debts and other income.Segment assets do not include cash and cash equivalents, investments, prepayments and other receivables, and property and equipment, net.Segment liabilities do not include reinsurance payables, accrued expenses and other liabilities, due to shareholders’ operations and employees’ terminal benefits | 19 |
| Disclosure of comparative figures [text block] | 31. COMPARATIVE FIGURESCertain prior year figures have been reclassified to conform to current year presentation. Such reclassifications have not resulted in any additional impact on equity, income or total comprehensive income for comparative years. | 31 |
| Disclosure of board of director's approval of the financial statements [text block] | 32. APPROVAL OF THE FINANCIAL STATEMENTSThese financial statements have been approved by the Board of Directors on 16 March 2021 corresponding to 3 Sha’aban 1442H. | 32 |
| Disclosure of other notes relevant to understanding of financial statements [text block] |
SUPPLEMENTARY INFORMATION
STATEMENT OF FINANCIAL POSITION
| 31 December 2020 | 31 December 2019 |
| Insurance operations | Share-holders’ operations | Total | Insurance operation | Share-holders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | ASSETS |
|
|
|
|
|
| Cash and cash equivalents | 72,725 | 75,251 | 147,976 | 65,320 | 12,159 | 77,479 | Term deposits | 119,331 | - | 119,331 | 138,920 | 55,663 | 194,583 | Premiums and reinsurers’ receivable, net | 98,638 | - | 98,638 | 88,140 | - | 88,140 | Reinsurers’ share of unearned premiums | 27,393 | - | 27,393 | 21,323 | - | 21,323 | Reinsurers’ share of outstanding claims | 11,908 | - | 11,908 | 9,718 | - | 9,718 | Reinsurers’ share of claims incurred but not reported | 8,020 | - | 8,020 | 6,597 | - | 6,597 | Deferred policy acquisition cost | 31,659 | - | 31,659 | 14,157 | - | 14,157 | Due from a related party | 1,985 | - | 1,985 | 1,760 | - | 1,760 | Property and equipment, net | 5,314 | - | 5,314 | 3,598 | - | 3,598 | Intangible assets | 4,751 | - | 4,751 | 5,008 | - | 5,008 | Right of use asset, net | 5,222 | - | 5,222 | 7,227 | - | 7,227 | Available-for-sale investments | - | 49,259 | 49,259 | - | 51,106 | 51,106 | Prepayments and other receivables | 60,076 | 4,084 | 64,160 | 46,270 | 4,211 | 50,481 | Statutory deposit | - | 30,000 | 30,000 | - | 30,000 | 30,000 | Accrued commission on statutory deposit | - | 1,794 | 1,794 | - | 1,653 | 1,653 | TOTAL ASSETS | 447,022 | 160,388 | 607,410 | 408,038 | 154,792 | 562,830 |
|
|
|
|
|
|
| LIABILITIES |
|
|
|
|
|
| Policyholders claim payable | 10,142 | - | 10,142 | 1,506 | - | 1,506 | Accrued and other payables | 23,264 | 899 | 24,163 | 10,144 | 201 | 10,345 | Reinsurances balances payable | 16,661 | - | 16,661 | 16,470 | - | 16,470 | Unearned commission income | 1,426 | - | 1,426 | 1,339 | - | 1,339 | Unearned premiums | 264,469 | - | 264,469 | 254,360 | - | 254,360 | Premium deficiency reserve | 9,516 | - | 9,516 | 2,308 | - | 2,308 | Other technical reserve | 2,482 | - | 2,482 | 1,716 | - | 1,716 | Outstanding claims | 26,094 | - | 26,094 | 34,024 | - | 34,024 | Claims incurred but not reported | 68,643 | - | 68,643 | 61,887 | - | 61,887 | Employees’ terminal benefits | 14,006 | - | 14,006 | 12,011 | - | 12,011 | Lease liabilities | 4,974 | - | 4,974 | 7,122 | - | 7,122 | Surplus distribution payable | 6,409 | - | 6,409 | 5,982 | - | 5,982 | Accrued zakat and income tax | - | 11,000 | 11,000 | - | 8,479 | 8,479 | Accrued commission on statutory deposit payable to SAMA | - | 1,794 | 1,794 | - | 1,653 | 1,653 |
|
|
|
|
|
|
| TOTAL LIABILITIES | 448,086 | 13,693 | 461,779 | 408,869 | 10,333 | 419,202 |
|
|
|
|
|
|
| EQUITY |
|
|
|
|
|
| Share capital | - | 141,000 | 141,000 | - | 200,000 | 200,000 | Accumulated losses | - | (1,431) | (1,431) | - | (59,514) | (59,514) | Fair value reserve on available-for-sale investments | - | 7,126 | 7,126 | - | 3,973 | 3,973 | TOTAL SHAREHOLDER’S EQUITY | - | 146,695 | 146,695 | - | 144,459 | 144,459 | Re-measurement reserve of employees’ terminal benefits | (1,064) | - | (1,064) | (831) | - | (831) | TOTAL EQUITY | (1,064) | 146,695 | 145,631 | (831) | 144,459 | 143,628 | TOTAL LIABILITIES AND EQUITY | 447,022 | 160,388 | 607,410 | 408,038 | 154,792 | 562,830 |
SUPPLEMENTARY INFORMATION – (continued)
STATEMENT OF INCOME
| 31 December 2020 | 31 December 2019 |
| Insurance operations | Share-holders’ operations | Total | Insurance operations | Share-holders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | REVENUES |
|
|
|
|
|
| Gross premiums written | 515,117 | - | 515,117 | 529,352 | - | 529,352 | Reinsurance premiums ceded |
|
|
|
|
|
| -Local | (4,096) | - | (4,096) | (4,486) | - | (4,486) | -Foreign | (57,037) | - | (57,037) | (49,716) | - | (49,716) |
| (61,133) | - | (61,133) | (54,202) | - | (54,202) | Excess of loss premiums |
|
|
|
|
|
| -Local | (2,344) | - | (2,344) | (1,713) | - | (1,713) | -Foreign | (2,180) | - | (2,180) | (2,570) | - | (2,570) |
| (4,524) | - | (4,524) | (4,283) | - | (4,283) | NET PREMIUMS WRITTEN | 449,460 | - | 449,460 | 470,867 | - | 470,867 | Changes in unearned premiums, net | (4,039) | - | (4,039) | (3,768) | - | (3,768) | NET PREMIUMS EARNED | 445,421 | - | 445,421 | 467,099 | - | 467,099 | Reinsurance commission earned | 4,112 | - | 4,112 | 3,751 | - | 3,751 | Other underwriting income | 6,260 | - | 6,260 | 2,251 | - | 2,251 | NET REVENUES | 455,793 | - | 455,793 | 473,101 | - | 473,101 |
|
|
|
|
|
|
| Gross claims paid | 382,842 | - | 382,842 | 399,682 | - | 399,682 | Reinsurers’ share of claims paid | (38,123) | - | (38,123) | (36,330) | - | (36,330) | NET CLAIMS PAID | 344,719 | - | 344,719 | 363,352 | - | 363,352 | Changes in outstanding claims, net | (10,120) | - | (10,120) | (7,569) | - | (7,569) | Changes in incurred but not reported, net | 5,333 | - | 5,333 | 5,525 | - | 5,525 | NET CLAIMS INCURRED | 339,932 | - | 339,932 | 361,308 | - | 361,228 | Changes in other technical reserve | 766 | - | 766 | (80) | - | (80) | Change in premium deficiency reserve | 7,207 | - | 7,207 | 288 | - | 288 | Policy acquisition costs | 30,632 | - | 30,632 | 25,288 | - | 25,288 | Other underwriting expenses | 5,733 | - | 5,733 | 5,949 | - | 5,949 | TOTAL UNDERWRITING COST AND EXPENSES | 384,270 | - | 384,270 | 392,753 | - | 392,753 |
|
|
|
|
|
|
| NET UNDERWRITING INCOME | 71,523 | - | 71,523 | 80,348 | - | 80,348 | OTHER OPERATING (EXPENSE) / INCOME |
|
|
|
|
|
| Release of doubtful debts | 4,354 | - | 4,354 | 227 | - | 227 | General and administrative expenses | (73,469) | (3,122) | (76,591) | (79,932) | (2,265) | (82,197) | Commission income on deposits | 2,138 | 510 | 2,648 | 4,580 | 1,594 | 6,174 | Investment income | - | 2,056 | 2,056 | - | 3,063 | 3,063 | Other income | 12 | - | 12 | 25 | - | 25 | TOTAL OTHER OPERATING (EXPENSES) / INCOME | (66,965) | (556) | (67,521) | (75,100) | 2,392 | (72,708) |
|
|
|
|
|
|
|
SUPPLEMENTARY INFORMATION – (continued)
STATEMENT OF INCOME - (continued)
| 31 December 2020 | 31 December 2019 |
| Insurance operations | Share-holders’ operations | Total | Insurance operations | Share-holders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 |
|
|
|
|
|
|
| Total income for the year before zakat and income tax and surplus attribution" | 4,558 | (556) | 4,002 | 5,248 | 2,392 | 7,640 | Zakat charge for the year | - | (4,463) | (4,463) | - | (5,396) | (5,396) | (LOSS) / INCOME FOR THE YEAR | 4,558 | (5,019) | (461) | 5,248 | (3,004) | 2,244 | NET INCOME ATTRIBUTED TO THE SHAREHOLDER OPERATIONS | (4,102) | 4,102 | - | (4,723) | 4,723 | - | Net result after transfer of surplus to shareholders | 456 | (917) | (461) | 525 | 1,719 | 2,244 | Weighted average number of ordinary shares outstanding (in thousands) |
| 14,100 |
|
| 14,100 |
| Basic and diluted (loss) / earnings per share for the year |
| (0.07) |
|
| 0.12 |
|
|
|
|
|
|
|
| Income for the year | 456 | (917) | (461) | 525 | 1,719 | 2,244 | OTHER COMPREHENSIVE INCOME / (LOSS) |
|
|
|
|
|
| ITEMS THAT WILL NOT BE RECLASSIFIED TO STATEMENT OF INCOME IN SUBSEQUENT PERIODS |
|
|
|
|
|
| - Actuarial gains / (losses) on employees’ terminal benefits | (233) | - | (233) | (471) | - | (471) |
|
|
|
|
|
|
| ITEMS THAT ARE OR MAY BE RECLASSIFIED TO STATEMENTS OF INCOME IN SUBSEQUENT PERIOD |
|
|
|
|
|
| - Available-for-sale investments: |
|
|
|
|
|
| - Net change in fair value | - | 3,154 | 3,154 | - | 4,732 | 4,732 | TOTAL COMPREHENSIVE INCOME FOR THE YEAR | 223 | 2,236 | 2,459 | 54 | 6,451 | 6,505 |
SUPPLEMENTARY INFORMATION – (continued)
STATEMENT OF CASH FLOWS
| 31 December 2020 | 31 December 2019 | |
| Insurance operations | Share-holders’ operations | Total | Insurance operations | Share-holders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | CASH FLOWS FROM OPERATING ACTIVITIES |
|
|
|
|
|
| Net income for the year before zakat and income tax | 456 | 3,546 | 4,002 | 525 | 7,115 | 7,640 | Adjustments for non-cash items: |
|
|
|
|
|
| Depreciation of property and equipment | 1,726 | - | 1,726 | 2,226 | - | 2,226 | Amortization of right of use assets | 2,093 | - | 2,093 | 2,758 | - | 2,758 | Finance cost of lease liability | 287 | - | 287 | 321 | - | 321 | Amortization of intangible assets | 989 | - | 989 | 914 | - | 914 | Provision for employees’ terminal benefits | 2,315 | - | 2,315 | 2,268 | - | 2,268 | Release of doubtful debts | (4,354) | - | (4,354) | (227) | - | (227) |
|
|
|
|
|
|
| Changes in operating assets and liabilities: |
|
|
|
|
|
| Premiums and reinsurers’ receivable | (6,144) | - | (6,144) | 6,065 | - | 6,065 | Reinsurers’ share of unearned premiums | (6,070) | - | (6,070) | 1,415 | - | 1,415 | Reinsurers’ share of outstanding claims | (2,190) | - | (2,190) | 825 | - | 825 | Reinsurers’ share of claims incurred but not reported | (1,423) | - | (1,423) | (593) | - | (593) | Deferred policy acquisition costs | (17,502) | - | (17,502) | (2,107) | - | (2,107) | Due from related party | (225) | - | (225) | 631 | - | 631 | Prepayments and other receivables | (13,806) | 127 | (13,679) | (18,223) | 2,391 | (15,832) | Policyholders claim payables | 8,636 | - | 8,636 | (7,235) | - | (7,235) | Accrued and other payables | 13,120 | 697 | 13,817 | (6,872) | (84) | (6,956) | Reinsurance balances payable | 191 | - | 191 | 4,965 | - | 4,965 | Unearned commission income | 87 | - | 87 | 73 | - | 73 | Unearned premiums | 10,109 | - | 10,109 | 2,353 | - | 2,353 | Premium deficiency reserve | 7,208 | - | 7,208 | 288 | - | 288 | Other technical reserves | 766 | - | 766 | (80) | - | (80) | Outstanding claims | (7,930) | - | (7,930) | (8,395) | - | (8,395) | Claims incurred but not reported | 6,756 | - | 6,756 | 6,118 | - | 6,118 |
| (4,905) | 4,370 | (535) | (11,987) | 9,422 | (2,565) |
|
|
|
|
|
|
| Employees’ terminal benefits paid | (553) | - | (553) | (517) | - | (517) | Surplus paid to policyholder | (29) | - | (29) | - | - | - | Zakat and income tax paid | - | (1,941) | (1,941) | - | (2,029) | (2,029) | Net cash (used in) / from operating activities | (5,487) | 2,429 | (3,058) | (12,504) | 7,393 | (5,111) |
SUPPLEMENTARY INFORMATION – (continued)
STATEMENT OF CASH FLOWS – (continued)
| 31 December 2020 | 31 December 2019 | |
| Insurance operations | Share-holders’ operations | Total | Insurance operations | Share-holders’ operations | Total |
| SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | SR '000 | CASH FLOWS FROM INVESTING ACTIVITIES |
|
|
|
|
|
| Purchase of property and equipment | (735) | - | (735) | (379) | - | (379) | Proceed from sale of property and equipment | 2,707 | - | 2,707 | - | - | - | Purchase of Intangible assets | (732) | - | (732) | (1,358) | - | (1,358) | Addition in right of use assets | (88) | - | (88) | - | - | - | Maturity / (placement) of term deposits | 19,589 | 55,663 | 75,252 | (664) | (6,680) | (7,344) | Purchase from sale of available-for-sale investment | - | - | - | - | (10,218) | (10,218) | Proceed from sale of available-for-sale investment | - | 5,000 | 5,000 | - | 21,578 | 21,578 | Net cash from / (used in) investing activities | 15,327 | 60,663 | 75,990 | (2,401) | 4,680 | 2,279 |
|
|
|
|
|
|
| CASH FLOWS FROM FINANCING ACTIVITIES |
|
|
|
|
|
| Decrease in statutory deposits | - | - | - | - | (10,000) | (10,000) | Payment of lease liability | (2,435) | - | (2,435) | (3,184) | - | (3,184) | Net change used in financing activities | (2,435) | - | (2,435) | (3,184) | (10,000) | (13,184) |
|
|
|
|
|
|
|
|
|
|
|
|
|
| Net change in cash and cash equivalents | 7,405 | 63,092 | 70,497 | (18,089) | 2,073 | (16,016) | Cash and cash equivalents, beginning of the year | 65,320 | 12,159 | 77,479 | 83,409 | 10,086 | 93,495 | Cash and cash equivalents, end of the year | 72,725 | 75,251 | 147,976 | 65,320 | 12,159 | 77,479 |
|
|
|
|
|
|
| NON-CASH INFORMATION |
|
|
|
|
|
|
|
|
|
|
|
|
| Net change in fair value of available-for-sale investments | - | 3,153 | 3,153 | - | 4,732 | 4,732 |
IMPACT OF COVID-19
The World Health Organisation declared the corona virus (COVID-19) to be a global pandemic on 11 March 2020, escalating from a declaration of a public health emergency on 30 January 2020. COVID-19 has had unexpected human and economic consequences across many countries and has resulted in significant market volatility.
COVID-19 pandemic continues to disrupt global markets as many geographies are beginning to experience a “second wave” of infections despite having previously controlled the outbreak through aggressive precautionary measures such as imposing restrictions on travel, lockdowns and strict social distancing rules. The Government of Kingdom of Saudi Arabia (“the Government”) however has managed to successfully control the outbreak to date, owing primarily to the effective measures taken by the Government, following which the Government has now ended the lockdowns and has begun taking phased measures to normalize international travel and resume Umrah pilgrimages.
The Company continues to be cognisant of both the micro and macroeconomic challenges that COVID-19 has posed, the teething effects of which may be felt for some time and is closely monitoring its exposures at a granular level, while maintaining acceptable service levels and operational activities and ensuring the safety and wellbeing of its employees.
Management of the Company is closely monitoring the situation as it evolves which is outlined on the broad dimensions as below:
Business impact
Impact on sales, receivables and product/pricing strategies
The major impact of COVID-19 pandemic is seen in medical and motor line of business as explained below. As with any estimate, the projections and likelihoods of occurrence are underpinned by significant judgment and rapidly evolving situation and uncertainties surrounding the duration and severity of the pandemic, and therefore, the actual outcomes may be different to those projected. The impact of such uncertain economic environment is judgmental, and the Company will continue to reassess its position and the related impact on a regular basis.
The key factors that impacted the 2020 production were market dynamics, the consumer spending and the insurance industry outlook and initiatives. Market dynamics involved the reduced Government spending and curtailment of projects due to COVID-19 situation. On the consumer side there was a clear tendency of the consumers to reduce cost and to shop for the cheapest solution.
There has been a limited impact on collections and liquidity during the current phase and this is being monitored regularly by management. Overall, product and pricing strategies continue to be on track and hence management does not see any significant changes presently.
Based upon the current trends, management has updated its sales forecasts to reflect these for the future. Management will continue to monitor the impact and update the forecasts further considering the situation as it continues to evolve.
IMPACT OF COVID-19 – (continued)
Business impact - (continued)
Impact on claims and reserving
Medical technical reserves
During the peak period of COVID-19 pandemic’s first wave i.e. March to June 2020, access to providers and demand for healthcare declined temporarily due to measures taken by the local authorities. This resulted in a substantial drop in incurred claims from April through May which began to recover in June reaching pre-COVID-19 claims levels by the end of the second quarter. At this stage, the Company continues to expect a significant portion of the untreated health conditions to rebound as health care patterns are gradually restored and hence expects a surge in expected future claims.
The propensity of a particular type of claim to be deferred depends on the nature of the medical condition and the types of diagnostic investigation and treatment associated with it. The expected surge in future claims related to insurance contracts in force was explicitly considered in the Premium Deficiency Reserve (PDR) estimation.
With reference to SAMA’s circular 173, dated 16/01/2019, insurance companies are required to hold an additional PDR in case the relevant Unearned Premium Reserve (UPR) is insufficient against the corresponding projected claims and expenses. To be adequate to meet the future insurance liabilities of the unexpired risk, the PDR calculation for the 2020 after considering the expected surge in claims resulted in recognizing on 5.06 million (2019: 2.3 million).
Motor technical reserves
In response to the COVID-19 pandemic, SAMA issued a circular 189 (the “circular”) dated 08 May 2020 to all insurance companies in the Kingdom of Saudi Arabia. Amongst other things, the circular instructed insurance companies to extend the period of validity of all existing retail motor insurance policies by further two months as well as providing a two-month additional coverage for all new retail motor policies written within one month of this circular.
Management, in conjunction with its appointed actuary, deliberated on a variety of internal factors and concluded, that the Company considers the extension of two months in exiting motor policies as new policy and to record a premium deficiency reserve based on the expected claims for the extended two months’ period.
For new policies written as per the above circular, the premium is earned over the period of coverage i.e. 14 months as per the Company’s accounting policy. There is no significant impact of two-month extension in earned premium as of 31 December 2020 as no material amounts of premium have been written during the one-month period.
The Company has performed a liability adequacy test using current estimates of future cash flows under its insurance contracts at an aggregated level for motor line of business and recorded a premium deficiency reserve amounting to SAR 4.46 million as at 31 December 2020 (31 December 2019: Nil).
Reinsurers continue to settle their share of the claims in line with the treaty and contracts with no adverse impact to business. Management continues to conduct regular reviews on the Company’s reinsurers in relation to the counterparty credit ratings, financial metrics, credit outlook and changes to their structures, if any.
The reserving towards IBNR continues to be consistent with the methodology and techniques applied as at 31 December 2019 and it factors the actual claim experience in the year ended 31 December 2020.
IMPACT OF COVID-19 – (continued)
Business impact - (continued)
Impact on expenses
The Company continues to maintain its staff in the normal course of business and pay the salaries.
Some of the expenses such as communication, technology and maintenance costs have increased due to the higher level of support to extend remote working options for the employees as well as costs towards sanitizing, social distancing and providing a safe environment for those employees working from the office. The additional costs have been partially offset with the lower costs towards business travel, conveyance and lower discretionary spending.
Impact on financial assets
In line with the impact upon the capital markets and interest-rates in the initial period of the pandemic in March 2020, there was some volatility and impact on the investment valuation which has recovered during the year ended December 31, 2020. The determination of fair value considers observable market information, determining whether specific markets are active or inactive, and whether transactions in inactive markets are deemed to be disorderly (i.e. forced or distressed), with none noted for the portfolio of available-for-sale financial assets held by the Company.
The Company continued to assess whether there is an objective evidence that a financial asset or a group of financial assets is impaired. During the year, the Company applied the accounting policy for impairment of financial assets consistent with prior year. With respect to insurance and reinsurance receivables, the Company is closely monitoring the credit quality of its customers and reinsurance companies and updating the allowance for impairment whenever there is an objective evidence of credit impairment.
Operational resilience and business continuity
From the initial stages of the COVID-19 pandemic, the Company set-up business continuity committee which frequently meets and reviews the operational, continuity, security, health and safety matters for the Company.
This includes rolling out several key guidelines with respect to systems availability, continuity of service to our customers, employee health and safety guidelines, travel restrictions, social distancing, rotational remote-working, exposure policy, travel guidelines in case required for personal reasons and other related matters. The IT systems availability and the business continuity procedures in terms of data back-up and recovery remain intact in the current situation.
Accounting and financial reporting
In the current phase of COVID-19 pandemic, the Company continues to apply its accounting policies consistently without deviation. Considering the impact on the business is limited, management continues to adopt a consistent approach to the use of estimates in the financial information. As the situation evolves in future, management will continue to monitor and consider updates as appropriate at that time.
The Company continues to maintain a healthy solvency ratio (note 29) and sound liquidity position during this phase.
Liquidity is being monitored regularly and a limited impact until the period of the financial information is noted. Management continues to track the developments. | 30 |
| Disclosure of derivatives and hedges[text block] | 26. CAPITAL MANAGEMENTObjectives are set by the Company to maintain healthy capital ratios in order to support its business objectives and maximize shareholders’ value.The Company manages its capital requirements by assessing shortfalls between reported and required capital levels on a regular basis. Adjustments to current capital levels are made in light of changes in market conditions and risk characteristics of the Company’s activities. In order to maintain or adjust the capital structure, the Company may adjust the amount of dividends paid to shareholders or issue shares.The Company manages its capital to ensure that it is able to continue as going concern and comply with the regulators’ capital requirements of the markets in which the Company operates while maximizing the return to stakeholders through the optimization of the debt and equity balance. The capital structure of the Company consists of equity attributable to equity holders comprising paid share capital, reserves and retained earnings. As per guidelines laid out by SAMA in Article 66 of the Implementing Insurance Regulations detailing the solvency margin required to be maintained, the Company shall maintain solvency margin equivalent to the highest of the following three methods as per SAMA Implementing Regulations: Minimum Capital Requirement of SAR 100 million Premium Solvency Margin Claims Solvency MarginThe Company is in compliance with all externally imposed capital requirements with sound solvency margin. The capital structure of the Company as at 31 December 2020 consists of paid-up share capital of SAR 141 million and accumulated losses of SAR 1.43 million (31 December 2019: paid-up share capital of SAR 200 million and accumulated losses of SAR 59.51 million.) in the statement of financial position.In the opinion of the Board of Directors, the Company has fully complied with the externally imposed capital requirements during the reported financial period. | 26 |